https://www.pharmaceutical-business-review.com/news/ab-sciex-indigo-to-market-automation-solutions-for-research-and-forensic-toxicology-170112/ 2012-01-16T18:43:00+00:00 https://www.pharmaceutical-business-review.com/news/ferring-deploys-cegedim-healthcare-solutions-170112/ 2012-01-16T23:07:00+00:00 https://www.pharmaceutical-business-review.com/news/synta-reports-favorable-results-of-ganetespib-docetaxel-combination-study-170112/ 2012-01-17T00:06:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-takes-over-epigenetics-research-work-and-assets-from-astex-170112/ 2012-01-17T00:32:00+00:00 https://www.pharmaceutical-business-review.com/news/lonestar-secures-diabetes-therapy-license-from-university-of-texas-170112/ 2012-01-17T00:36:00+00:00 https://www.pharmaceutical-business-review.com/news/medicago-cellectis-to-enhance-therapeutic-proteins-170112/ 2012-01-17T01:06:00+00:00 https://www.pharmaceutical-business-review.com/news/vidacare-study-reveals-io-infusion-equivalent-to-iv-in-therapeutic-hypothermia-170112/ 2012-01-17T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/brainstorm-als-treatment-yields-positive-safety-data-170112/ 2012-01-17T02:10:00+00:00 https://www.pharmaceutical-business-review.com/news/carbogen-amcis-acquires-creapharm-parenterals-170112/ 2012-01-17T02:14:00+00:00 https://www.pharmaceutical-business-review.com/news/dishman-inks-distribution-deal-with-charles-bowman-in-us-170112/ 2012-01-17T02:20:00+00:00 https://www.pharmaceutical-business-review.com/news/life-technologies-daan-gene-form-molecular-diagnostics-jv-in-china-170112/ 2012-01-17T02:22:00+00:00 https://www.pharmaceutical-business-review.com/news/source-omega-cerenate-dha-receives-singapore-nod-170112/ 2012-01-17T02:28:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-harvard-university-in-new-kidney-disease-research-alliance-170112/ 2012-01-17T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/scil-proteins-actavis-enter-reteplase-manufacturing-deal-170212/ 2012-01-17T05:02:00+00:00 https://www.pharmaceutical-business-review.com/news/synutra-infant-formula-receives-chinese-approval-170112/ 2012-01-17T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/natco-pharma-to-commence-galtiramer-acetate-production-for-mylan-170112/ 2012-01-17T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/stallergenes-chooses-magic-software-ibolt-solution-180112/ 2012-01-17T22:54:00+00:00 https://www.pharmaceutical-business-review.com/news/medivation-pfizer-report-dimebon-in-alzheimers-trial-fails-to-meet-primary-end-point-180112/ 2012-01-17T23:55:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-regorafenib-meets-correct-trial-endpoints-180112/ 2012-01-18T00:21:00+00:00 https://www.pharmaceutical-business-review.com/news/complegen-delivers-drug-discovery-technology-to-boehringer-180112/ 2012-01-18T00:23:00+00:00 https://www.pharmaceutical-business-review.com/news/constellation-genentech-strike-drug-development-deal-180112/ 2012-01-18T00:26:00+00:00 https://www.pharmaceutical-business-review.com/news/apricus-secures-allowance-for-israeli-patent-of-premature-ejaculation-cream-180112/ 2012-01-18T02:26:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-xenoport-regnite-tablet-secures-japanese-approval-180112/ 2012-01-18T02:34:00+00:00 https://www.pharmaceutical-business-review.com/news/hemispherx-secures-new-us-patents-for-alferon-ldo-180112/ 2012-01-18T02:37:00+00:00 https://www.pharmaceutical-business-review.com/news/jpt-iuct-leitat-enter-deal-on-anticancer-therapies-development-180112/ 2012-01-18T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-uk-introduces-latanoprost-eye-drops-180112/ 2012-01-18T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/celldex-initiates-patient-dosing-in-cdx-301study-180112/ 2012-01-18T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/antares-signs-licensing-deal-with-daewoong-for-oxybutynin-gel-3-180112/ 2012-01-18T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/btg-voraxaze-secures-fda-nod-180112/ 2012-01-18T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/dara-acquires-rights-to-sell-soltamox-in-us-180112/ 2012-01-18T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/mgb-biopharma-signs-contract-manufacturing-deal-with-almac-180112/ 2012-01-18T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/paragon-secures-filovirus-vaccine-development-and-manufacturing-contract-180112/ 2012-01-18T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/vivus-reports-phase-3-study-results-of-avanafil-180112/ 2012-01-18T08:01:00+00:00 https://www.pharmaceutical-business-review.com/news/waters-tecan-enter-clinical-assay-deal-180112/ 2012-01-18T08:12:00+00:00 https://www.pharmaceutical-business-review.com/news/nds-nutrition-products-unveils-new-nutritional-supplements-190112/ 2012-01-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/linezolid-found-superior-to-treat-mrsa-study-reports-190112/ 2012-01-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ono-pharma-selects-medidata-rave-solution-190112/ 2012-01-18T22:27:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-amd-drug-receives-chinese-approval-190112/ 2012-01-18T23:31:00+00:00 https://www.pharmaceutical-business-review.com/news/hi-tech-buys-hylase-wound-gel-distribution-rights-from-glycobiosciences-190112/ 2012-01-19T00:09:00+00:00 https://www.pharmaceutical-business-review.com/news/hybrid-fuels-launches-male-enhancement-supplement-190112/ 2012-01-19T00:24:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-gilead-hiv-drug-nda-190112/ 2012-01-19T00:27:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-grants-odd-to-ceptaris-chlormethine-gel-190112/ 2012-01-19T00:29:00+00:00 https://www.pharmaceutical-business-review.com/news/norgine-apr-labtec-sign-setofilm-licensing-deal-190112/ 2012-01-19T00:49:00+00:00 https://www.pharmaceutical-business-review.com/news/inflarx-completes-phase-i-study-of-ifx-1-190112/ 2012-01-19T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/us-hospital-selects-quadramed-identity-management-solutions-190112/ 2012-01-19T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-approves-genzyme-framingham-manufacturing-plant-190112/ 2012-01-19T01:50:00+00:00 https://www.pharmaceutical-business-review.com/news/pii-expands-cgmp-aseptic-facilities-190112/ 2012-01-19T03:54:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-crl-for-bristol-myers-astrazeneca-diabetes-drug-nda-190112/ 2012-01-19T04:11:00+00:00 https://www.pharmaceutical-business-review.com/news/huya-tipr-forge-drug-development-alliance-190112/ 2012-01-19T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-launches-generic-oral-contraceptive-product-190112/ 2012-01-19T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/sohm-indian-nutraceutical-plant-commences-production-190112/ 2012-01-19T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/global-health-trax-rolls-out-two-new-nutritional-supplements-190112/ 2012-01-19T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/prolor-announces-positive-results-from-post-phase-ii-hgh-ctp-study-190112/ 2012-01-19T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/zynx-supplies-prime-a-pump-tool-to-us-medical-center-200112/ 2012-01-19T22:42:00+00:00 https://www.pharmaceutical-business-review.com/news/ferrer-to-begin-antibacterial-compound-phase-iii-trials-200112/ 2012-01-19T23:48:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-new-antiepileptic-drug-200112/ 2012-01-19T23:53:00+00:00 https://www.pharmaceutical-business-review.com/news/ssb-g-con-collaborate-to-offer-new-production-process-platform-200112/ 2012-01-20T00:18:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-division-begins-phase-iii-clinical-trials-200112/ 2012-01-20T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/adeona-commences-multiple-sclerosis-drug-trial-200112/ 2012-01-20T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/clovis-co-1686-wins-fda-nda-approval-200112/ 2012-01-20T01:36:00+00:00 https://www.pharmaceutical-business-review.com/news/lts-nutraceuticals-acquires-biocalth-200112/ 2012-01-20T02:28:00+00:00 https://www.pharmaceutical-business-review.com/news/shangpharma-reaches-first-milestone-in-research-partnership-with-hengrui-200112/ 2012-01-20T02:31:00+00:00 https://www.pharmaceutical-business-review.com/news/apothecary-signs-distribution-agreement-with-regeneron-for-eylea-200112/ 2012-01-20T03:19:00+00:00 https://www.pharmaceutical-business-review.com/news/cutispharma-launches-new-oral-suspension-prescription-compounding-kits-200112/ 2012-01-20T03:23:00+00:00 https://www.pharmaceutical-business-review.com/news/medicago-to-develop-new-vlp-vaccine-candidate-for-rabies-200112/ 2012-01-20T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-biotech-firm-takes-over-warwick-effect-polymers-200112/ 2012-01-20T04:53:00+00:00 https://www.pharmaceutical-business-review.com/news/sabi-introduces-health-and-wellness-products-200112/ 2012-01-20T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/genta-reports-tesetaxel-phase-2b-trial-data-200112/ 2012-01-20T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/patheon-procaps-sign-soft-gel-development-deal-200112/ 2012-01-20T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/idera-reports-encouraging-data-from-phase-1b-nsclc-study-230112/ 2012-01-22T23:54:00+00:00 https://www.pharmaceutical-business-review.com/news/bbr-receives-us-patent-for-cd14-molecule-230112/ 2012-01-23T00:43:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-tysabri-label-change-230112/ 2012-01-23T00:48:00+00:00 https://www.pharmaceutical-business-review.com/news/galena-initiates-phase-iii-present-trial-for-neuvax-230112/ 2012-01-23T02:42:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-veracyte-sign-co-promotion-partnership-for-afirma-230112/ 2012-01-23T02:45:00+00:00 https://www.pharmaceutical-business-review.com/news/novadel-terminates-license-agreements-with-talon-and-par/ 2012-01-23T04:22:00+00:00 https://www.pharmaceutical-business-review.com/news/la-jolla-buys-gcs-100-from-solana-230112/ 2012-01-23T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/polytherics-purchases-warwick-effect-polymers-230112/ 2012-01-23T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-receives-us-patent-for-anticancer-compound-230112/ 2012-01-23T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/immunomedics-reports-favourable-phase-ibii-pancreatic-cancer-study-data-230112/ 2012-01-23T07:44:00+00:00 https://www.pharmaceutical-business-review.com/news/parexel-establishes-research-alliance-with-uh-bristol-240112/ 2012-01-23T23:45:00+00:00 https://www.pharmaceutical-business-review.com/news/trius-receives-5m-milestone-payment-from-bayer-240112/ 2012-01-23T23:48:00+00:00 https://www.pharmaceutical-business-review.com/news/tga-sanguine-enter-co-marketing-deal-for-bioassay-development-240112/ 2012-01-23T23:49:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-files-azelastine-hydrochloride-nasal-spray-anda-with-fda-230112/ 2012-01-24T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/spectrum-reports-encouraging-results-from-zevalin-study-240112/ 2012-01-24T01:06:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-receives-fda-approval-for-us-manufacturing-plant-240112/ 2012-01-24T02:15:00+00:00 https://www.pharmaceutical-business-review.com/news/fmmu-biostar-sign-research-cooperation-agreement/ 2012-01-24T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/fresh-easy-launches-new-line-of-vitamins-and-supplements-240112/ 2012-01-24T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/santhera-regains-rights-to-develop-adrenergic-alpha-2-receptor-antagonist-240112/ 2012-01-24T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/upsher-smith-launches-new-prenatal-vitamin-240112/ 2012-01-24T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/ventirx-reports-positive-tlr8-agonist-preclinical-data-240112/ 2012-01-24T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/aptiv-solutions-selects-nextdocs-clinical-trial-management-solutions-250112/ 2012-01-24T20:09:00+00:00 https://www.pharmaceutical-business-review.com/news/amerinet-deploys-ghx-procure-to-pay-solutions-250112/ 2012-01-24T23:04:00+00:00 https://www.pharmaceutical-business-review.com/news/activus-pharma-signs-research-agreement-with-sosei-250112/ 2012-01-24T23:54:00+00:00 https://www.pharmaceutical-business-review.com/news/boston-sugardown-supplement-found-to-reduce-post-meal-blood-glucose-levels-250112/ 2012-01-25T00:01:00+00:00 https://www.pharmaceutical-business-review.com/news/granules-omnichem-to-start-production-in-2013-250112/ 2012-01-25T00:03:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-commences-hiv-drug-trial-250112/ 2012-01-25T00:49:00+00:00 https://www.pharmaceutical-business-review.com/news/verify-brand-launches-vb-enterprise-40-software-for-life-sciences-250112/ 2012-01-25T01:46:00+00:00 https://www.pharmaceutical-business-review.com/news/ikaria-ino-combination-product-gets-fda-orphan-drug-status-250112/ 2012-01-25T02:08:00+00:00 https://www.pharmaceutical-business-review.com/news/opko-signs-licensing-deal-for-prostate-cancer-tests-250112/ 2012-01-25T02:11:00+00:00 https://www.pharmaceutical-business-review.com/news/opko-to-acquire-als-distribuidora-250112/ 2012-01-25T02:16:00+00:00 https://www.pharmaceutical-business-review.com/news/oramed-oral-drug-delivery-technology-receives-australian-patent-250112/ 2012-01-25T02:24:00+00:00 https://www.pharmaceutical-business-review.com/news/biolinerx-genoscience-partner-to-develop-hepatitis-c-drug-250112/ 2012-01-25T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/coti-completes-compound-synthesis-in-aml-program-250112/ 2012-01-25T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/depomed-begins-phase-ii-parkinsons-disease-trial-250112/ 2012-01-25T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/hikma-joins-ergomed-for-cancer-drug-trials-250112/ 2012-01-25T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/radiopharmacus-signs-deal-to-manufacture-cellpoint-imaging-agent-250112/ 2012-01-25T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-implements-new-packaging-line-for-coagucheck-diagnostic-strips-250112/ 2012-01-25T06:40:00+00:00 https://www.pharmaceutical-business-review.com/news/selventa-receives-new-patent-for-discovery-of-biomarker-profiles-250112/ 2012-01-25T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-pharmaceuticals-buys-ascent-pharmahealth-250112/ 2012-01-25T07:18:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-terminates-equal-alliance-with-indian-firm-270112/ 2012-01-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/neurocrine-receives-fda-fast-track-designation-for-vmat2-260112/ 2012-01-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/broward-county-adopts-upp-irms360-enterprise-solution-suite-260112/ 2012-01-25T19:10:00+00:00 https://www.pharmaceutical-business-review.com/news/almirall-signs-research-partnership-with-galapagos-260112/ 2012-01-26T00:06:00+00:00 https://www.pharmaceutical-business-review.com/news/spectrum-signs-zevalin-licensing-deal-with-bayer-260112/ 2012-01-26T00:14:00+00:00 https://www.pharmaceutical-business-review.com/news/marina-initiates-cohort-2-of-start-fap-trial-with-ceq508-260112/ 2012-01-26T00:50:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-leo-pharma-picato-gel-260112/ 2012-01-26T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/pycnogenol-supplement-found-to-improve-skin-hydration-elasticity-260112/ 2012-01-26T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-epilepsy-drug-wins-fda-clearance-260112/ 2012-01-26T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/vaxiion-receives-us-patent-for-minicell-based-therapeutics-260112/ 2012-01-26T01:43:00+00:00 https://www.pharmaceutical-business-review.com/news/advaxis-announces-preliminary-trial-data-of-adxs-hpv-260112/ 2012-01-26T03:30:00+00:00 https://www.pharmaceutical-business-review.com/news/zogenix-and-battelle-to-advance-drug-delivery-technology-260112/ 2012-01-26T03:33:00+00:00 https://www.pharmaceutical-business-review.com/news/aphios-receives-phase-ii-sbir-grant-for-alzheimers-disease-research-260112/ 2012-01-26T04:10:00+00:00 https://www.pharmaceutical-business-review.com/news/navidea-enters-licensing-deal-with-alseres-260112/ 2012-01-26T04:14:00+00:00 https://www.pharmaceutical-business-review.com/news/afc-upgrades-facilities-to-manufacture-schedule-ii-controlled-substances-260112/ 2012-01-26T04:17:00+00:00 https://www.pharmaceutical-business-review.com/news/hanmi-enters-into-supply-contract-with-meic-260112/ 2012-01-26T04:23:00+00:00 https://www.pharmaceutical-business-review.com/news/obagi-medical-launches-two-new-aesthetic-products-260112/ 2012-01-26T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/prosensa-secures-financing-to-develop-rna-modulating-therapeutics-260112/ 2012-01-26T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/sams-club-introduces-new-line-of-vitamins-and-supplements-260112/ 2012-01-26T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/omnicell-reports-rise-in-q4-revenues-270112/ 2012-01-26T20:04:00+00:00 https://www.pharmaceutical-business-review.com/news/armada-definitive-homecare-strike-deal-for-specialty-pharmacy-software-and-services-270112/ 2012-01-26T22:02:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-reports-interim-data-from-adcetris-ctcl-trial-270112/ 2012-01-26T23:29:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-settles-exalgo-patent-litigation-with-mallinckrodt-270112/ 2012-01-26T23:32:00+00:00 https://www.pharmaceutical-business-review.com/news/charter-earns-ce-approval-for-cryogenic-stem-cell-storage-containers-270112/ 2012-01-26T23:50:00+00:00 https://www.pharmaceutical-business-review.com/news/lpath-suspends-dosing-in-pedigree-and-nexus-trials-270112/ 2012-01-26T23:58:00+00:00 https://www.pharmaceutical-business-review.com/news/hemispherx-receives-approval-for-alferon-n-injection-in-argentina-270112/ 2012-01-27T00:01:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-technoclone-enter-deal-for-coagulation-assays-development-270112/ 2012-01-27T00:04:00+00:00 https://www.pharmaceutical-business-review.com/news/mission-pharmacal-launches-new-subsidiary-270112/ 2012-01-27T00:07:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-micromet-sign-definitive-merger-agreement-270112/ 2012-01-27T03:26:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-elan-report-efficacy-of-tysabri-in-multiple-sclerosis-270112/ 2012-01-27T03:37:00+00:00 https://www.pharmaceutical-business-review.com/news/bioreference-launches-new-solid-tumor-genotyping-test-270112/ 2012-01-27T04:09:00+00:00 https://www.pharmaceutical-business-review.com/news/diagnocure-reports-diagnosis-results-of-colorectal-cancer-study-270112/ 2012-01-27T04:14:00+00:00 https://www.pharmaceutical-business-review.com/news/catalent-expands-drug-development-and-delivery-capabilities-270112/ 2012-01-27T04:18:00+00:00 https://www.pharmaceutical-business-review.com/news/elite-receives-fda-nod-for-supplemental-application-for-hydromorphone-270112/ 2012-01-27T04:26:00+00:00 https://www.pharmaceutical-business-review.com/news/albemarle-installs-new-production-train-for-finished-polyolefin-catalysts-270112/ 2012-01-27T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/premier-grants-octylseal-agreement-to-medline-270112/ 2012-01-27T05:11:00+00:00 https://www.pharmaceutical-business-review.com/news/dwh-cpdd-enter-drug-discovery-deal-270112/ 2012-01-27T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-grants-orphan-drug-status-to-celator-leukemia-drug-270112/ 2012-01-27T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/vanda-reports-positive-data-of-tasimelteon-in-non-24-hour-disorder-270112/ 2012-01-27T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/auxilium-doses-first-patients-in-xiaflex-phase-ib-trial-270112/ 2012-01-27T06:10:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-receives-fda-approval-for-advanced-rcc-drug-300112/ 2012-01-29T23:56:00+00:00 https://www.pharmaceutical-business-review.com/news/genvec-extends-research-collaboration-with-novartis-300112/ 2012-01-30T00:12:00+00:00 https://www.pharmaceutical-business-review.com/news/apricus-pediatrx-sign-co-promotion-agreement-for-granisol-and-aquoral-300112/ 2012-01-30T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-nda-for-pfizer-cml-drug-300112/ 2012-01-30T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/infinity-presents-interim-data-of-phase-2-study-in-metastatic-pancreatic-cancer-300112/ 2012-01-30T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-bydureon-for-type-2-diabetes-300112/ 2012-01-30T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-bio-initiates-orteronel-phase-iii-clinical-trials-in-japan-300112/ 2012-01-30T01:24:00+00:00 https://www.pharmaceutical-business-review.com/news/pinpoint-genomics-releases-pinpoint-dx-lung-assay-300112/ 2012-01-30T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/arabio-alphamed-enter-drug-distribution-deal-300112/ 2012-01-30T03:22:00+00:00 https://www.pharmaceutical-business-review.com/news/cell-therapeutics-withdraws-pixuvri-nda-300112/ 2012-01-30T03:25:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-delays-decision-on-amt-glybera-marketing-authorisation-300112/ 2012-01-30T03:39:00+00:00 https://www.pharmaceutical-business-review.com/news/btg-varisolve-phase-iii-trial-meets-efficacy-endpoints-300112/ 2012-01-30T06:29:00+00:00 https://www.pharmaceutical-business-review.com/news/dndi-abbott-sign-joint-research-non-exclusive-licensing-agreement-300112/ 2012-01-30T06:36:00+00:00 https://www.pharmaceutical-business-review.com/news/idmc-recommends-continuation-of-ziopharm-phase-iii-palifosfamide-study-300112/ 2012-01-30T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/precision-receives-us-patent-related-to-engineered-meganucleases-300112/ 2012-01-30T07:49:00+00:00 https://www.pharmaceutical-business-review.com/news/immunogen-reports-increase-in-q2-revenues-300112/ 2012-01-30T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/sigma-aldrich-takes-over-bioreliance-for-350m-310112/ 2012-01-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/kishhealth-system-adopts-thomson-reuters-pharmacy-xpert-310112/ 2012-01-30T23:04:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-receives-new-patent-for-second-generation-lnp-delivery-platform-310112/ 2012-01-30T23:50:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-eli-lilly-jentadueto-to-treat-type-2-diabetes-310112/ 2012-01-31T00:24:00+00:00 https://www.pharmaceutical-business-review.com/news/kinemed-signs-non-exclusive-research-collaboration-with-pfizer-310112/ 2012-01-31T00:27:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-to-establish-new-rd-technology-center-310112/ 2012-01-31T00:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ista-completes-patient-enrollment-in-phase-ii-allergic-rhinitis-study-310112/ 2012-01-31T02:18:00+00:00 https://www.pharmaceutical-business-review.com/news/durect-regains-posidur-rights-310112/ 2012-01-31T04:09:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-lannett-anda-for-hydrochlorothiazide-capsules-310112/ 2012-01-31T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-genentech-bcc-drug-310112/ 2012-01-31T04:22:00+00:00 https://www.pharmaceutical-business-review.com/news/idaho-files-for-fda-clearance-of-expanded-filmarray-respiratory-panel-310112/ 2012-01-31T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/integrative-therapeutics-introduces-occasional-anxiety-solution-in-us-310112/ 2012-01-31T04:32:00+00:00 https://www.pharmaceutical-business-review.com/news/rock-creek-anatabloc-lowers-chronic-inflammation-says-study-310112/ 2012-01-31T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/array-biopharma-reports-rise-in-q2-revenue-310112/ 2012-01-31T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/maxcyte-produces-gram-scale-antibody-and-protein-310112/ 2012-01-31T05:56:00+00:00 https://www.pharmaceutical-business-review.com/news/amag-completes-enrollment-in-phase-iii-ida-study-310112/ 2012-01-31T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/orexo-announces-termination-of-ox-cli-and-ox-esi-programs-310112/ 2012-01-31T07:47:00+00:00 https://www.pharmaceutical-business-review.com/news/zynx-health-provides-prime-a-pump-tool-to-us-hospital-010212/ 2012-01-31T19:17:00+00:00 https://www.pharmaceutical-business-review.com/news/covalent-launches-new-macular-health-eye-vitamin-010212/ 2012-01-31T23:48:00+00:00 https://www.pharmaceutical-business-review.com/news/ranbaxy-to-stop-drug-manufacturing-for-us-market-010212/ 2012-02-01T00:04:00+00:00 https://www.pharmaceutical-business-review.com/news/medivation-astellas-announce-positive-results-from-phase-iii-prostate-cancer-trial-010212/ 2012-02-01T00:16:00+00:00 https://www.pharmaceutical-business-review.com/news/lannett-receives-anda-approval-for-phentermine-hcl-capsules-010212/ 2012-02-01T00:31:00+00:00 https://www.pharmaceutical-business-review.com/news/alkermes-begins-vivitrol-pilot-study-in-prisoners-010212/ 2012-02-01T00:45:00+00:00 https://www.pharmaceutical-business-review.com/news/tibet-pharmaceuticals-to-extend-distribution-network-in-china-010212/ 2012-02-01T00:54:00+00:00 https://www.pharmaceutical-business-review.com/news/niaid-partners-with-aeras-for-new-tuberculosis-vaccine-trial-010212/ 2012-02-01T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/cytovance-expands-manufacturing-process-trains-010212/ 2012-02-01T01:25:00+00:00 https://www.pharmaceutical-business-review.com/news/nanoviricides-files-flucide-pre-ind-to-fda-010212/ 2012-02-01T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/clorox-launches-new-line-of-activated-hydrogen-peroxide-cleaner-disinfectants-010212/ 2012-02-01T04:04:00+00:00 https://www.pharmaceutical-business-review.com/news/hi-tech-receives-fda-approval-for-lorazepam-oral-concentrate-010212/ 2012-02-01T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/starpharma-dendrimer-technology-improves-efficacy-of-docetaxel-010212/ 2012-02-01T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/indoco-strikes-api-marketing-deal-with-dsm-010212/ 2012-02-01T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/targovax-secures-financing-to-develop-cancer-drug-010212/ 2012-02-01T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/tnt-express-offers-new-transport-service-for-temperature-sensitive-pharmaceuticals-010212/ 2012-02-01T06:36:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-astrazeneca-sign-licensing-deal-for-zomig-020212/ 2012-02-01T23:38:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-receives-fda-nod-for-gleevec-drug-label-change-020212/ 2012-02-01T23:59:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-partners-sangamo-to-develop-hemophilia-treatments-020212/ 2012-02-02T00:03:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-to-deploy-median-image-interpretation-management-solution-020212/ 2012-02-02T00:09:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-recalls-oral-contraceptives-due-to-packaging-error-020212/ 2012-02-02T01:17:00+00:00 https://www.pharmaceutical-business-review.com/news/affinium-doses-first-patient-in-afn-1252-drug-trial-020212/ 2012-02-02T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/parexel-amc-partner-to-advance-drug-development-programs-in-korea-020212/ 2012-02-02T01:24:00+00:00 https://www.pharmaceutical-business-review.com/news/bdi-pharma-deploys-zensar-sap-erp-and-crm-solutions-020212/ 2012-02-02T01:47:00+00:00 https://www.pharmaceutical-business-review.com/news/gnc-internet-storefront-to-offer-rock-creek-pharma-anatabloc-020112/ 2012-02-02T01:54:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-takes-over-probiotica-in-brazil-020212/ 2012-02-02T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/octoplus-ferring-strike-drug-manufacturing-deal-020212/ 2012-02-02T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/ablynx-receives-5m-milestone-payment-from-boehringer-020212/ 2012-02-02T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/athersys-secures-grants-to-advance-multistem-020212/ 2012-02-02T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/florida-biologix-aseptic-fill-finish-facility-meets-european-gmp-requirements-020212/ 2012-02-02T07:44:00+00:00 https://www.pharmaceutical-business-review.com/news/foundation-medicine-wins-clia-certification-for-genomic-sequencing-laboratory-020212/ 2012-02-02T07:48:00+00:00 https://www.pharmaceutical-business-review.com/news/masitinib-found-superior-to-standard-gist-treatment-ab-science-reports-020212/ 2012-02-02T07:54:00+00:00 https://www.pharmaceutical-business-review.com/news/nautilus-receives-us-patent-for-diclofenac-formulations-and-methods-020212/ 2012-02-02T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/celerion-selects-verified-participant-verification-system-030212/ 2012-02-02T21:47:00+00:00 https://www.pharmaceutical-business-review.com/news/sucampo-takeda-phase-iii-obd-trial-meets-primary-endpoint-030212/ 2012-02-02T23:36:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-gets-tentative-fda-nod-for-generic-lipitor-030212/ 2012-02-02T23:42:00+00:00 https://www.pharmaceutical-business-review.com/news/optinose-to-begin-phase-iii-trials-with-intranasal-technology-030212/ 2012-02-02T23:48:00+00:00 https://www.pharmaceutical-business-review.com/news/delmar-val-083-drug-gets-fda-orphan-drug-status-030212/ 2012-02-03T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/eusa-acquires-asparec-development-rights-from-aliz-pharma-030212/ 2012-02-03T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/nuvo-launches-synera-in-us-030212/ 2012-02-03T01:16:00+00:00 https://www.pharmaceutical-business-review.com/news/coti-develops-coti-2-phase-1-oral-formulation-030212/ 2012-02-03T03:23:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-bayer-radium-223-chloride-expanded-access-program/ 2012-02-03T03:37:00+00:00 https://www.pharmaceutical-business-review.com/news/geron-concludes-patient-enrollment-in-cancer-drug-trial-030212/ 2012-02-03T03:53:00+00:00 https://www.pharmaceutical-business-review.com/news/sgi-idt-partner-to-manufacture-synthetic-gene-products-030212/ 2012-02-03T03:58:00+00:00 https://www.pharmaceutical-business-review.com/news/tci-to-open-new-distribution-center-in-us-030212/ 2012-02-03T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/insero-enters-licensing-deals-to-produce-huperzine-030212/ 2012-02-03T05:56:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-receives-fda-approval-for-type-2-diabetes-therapy/ 2012-02-03T06:28:00+00:00 https://www.pharmaceutical-business-review.com/news/hybrid-fuels-selects-fda-approved-lab-for-azul-instan-030212/ 2012-02-03T06:49:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-threshold-partner-to-co-develop-hypoxia-targeted-drug-060212/ 2012-02-05T23:08:00+00:00 https://www.pharmaceutical-business-review.com/news/dalfampridine-found-to-improve-motor-function-060212/ 2012-02-05T23:29:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-removes-hold-on-idenix-hepatitis-drug-060212/ 2012-02-06T00:14:00+00:00 https://www.pharmaceutical-business-review.com/news/apricus-inks-nitromist-rights-deal-with-novadel-060212/ 2012-02-06T02:27:00+00:00 https://www.pharmaceutical-business-review.com/news/medicago-to-invest-in-pilot-production-facility-060212/ 2012-02-06T02:34:00+00:00 https://www.pharmaceutical-business-review.com/news/mission-pharmacal-buys-ferndale-eletone-cream-060212/ 2012-02-06T02:41:00+00:00 https://www.pharmaceutical-business-review.com/news/scm-pharma-brepco-to-manufacture-neonatal-product-060212/ 2012-02-06T02:50:00+00:00 https://www.pharmaceutical-business-review.com/news/ntrr-to-commence-pure-plus-clinical-trial-060212/ 2012-02-06T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-ziopharm-oral-palifosfamide-ind-060212/ 2012-02-06T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/clinuvel-submits-scenesse-maa-to-ema-060212/ 2012-02-06T07:47:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-suspends-four-trials-of-anacor-antibiotic-070212/ 2012-02-06T23:48:00+00:00 https://www.pharmaceutical-business-review.com/news/shanghai-to-acquire-major-stake-in-changzhou-kony-070212/ 2012-02-07T00:00:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-to-expand-manufacturing-facility-in-victoria-070212/ 2012-02-07T00:42:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-introduces-edarbyclor-drug-in-us-070212/ 2012-02-07T00:48:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-receives-european-approval-for-type-2-diabetes-drug-070212/ 2012-02-07T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-neurelis-intranasal-diazepam-ind-070212/ 2012-02-07T00:56:00+00:00 https://www.pharmaceutical-business-review.com/news/synchroneuron-closes-series-a-financing-with-morningside-070212/ 2012-02-07T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/acorda-watson-partner-to-introduce-generic-zanaflex-capsules-070212/ 2012-02-07T02:34:00+00:00 https://www.pharmaceutical-business-review.com/news/advinus-joins-cgh-to-develop-therapies-for-visceral-leishmaniasis-070212/ 2012-02-07T02:43:00+00:00 https://www.pharmaceutical-business-review.com/news/ucla-ert-initiate-clear-study-for-copd-patients-070212/ 2012-02-07T02:46:00+00:00 https://www.pharmaceutical-business-review.com/news/genetic-technologies-signs-license-agreement-with-eurofins-070212/ 2012-02-07T02:49:00+00:00 https://www.pharmaceutical-business-review.com/news/biolinerx-signs-licensing-deal-with-genoscience-rfs-pharma-070212/ 2012-02-07T02:52:00+00:00 https://www.pharmaceutical-business-review.com/news/cadence-recalls-single-lot-of-ofirmev-injection-070212/ 2012-02-07T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/gw-pharmaceuticals-to-launch-new-oromucosal-spray-in-austria-070212/ 2012-02-07T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-reports-positive-phase-iii-results-of-insomnia-drug-070212/ 2012-02-07T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/pieris-receives-bmbf-grant-to-develop-anti-ancaner-agent-070212/ 2012-02-07T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/musclepharm-expects-increase-in-q4-gross-revenues-070212/ 2012-02-07T07:31:00+00:00 https://www.pharmaceutical-business-review.com/news/rib-x-achieves-fourth-milestone-payment-in-sanofi-rx-04-collaboration-080212/ 2012-02-07T23:38:00+00:00 https://www.pharmaceutical-business-review.com/news/firstfitness-nutrition-launches-new-appetite-suppressant-080212/ 2012-02-07T23:43:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-shire-vyvanse-capsules-for-adhd-080212/ 2012-02-08T00:28:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-vorapaxar-meets-tra-2p-study-endpoints-080212/ 2012-02-08T00:32:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-purchases-two-dermatological-products-from-valeant-080212/ 2012-02-08T00:36:00+00:00 https://www.pharmaceutical-business-review.com/news/bio-path-completes-second-cohort-dosing-of-leukemia-drug-trial-080212/ 2012-02-08T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-gains-recombinant-factor-viii-factor-ix-manufacturing-rights-080212/ 2012-02-08T00:53:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-designation-for-crofelemer-nda-080212/ 2012-02-08T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/prismic-pharmaceuticals-takes-over-scarista-080212/ 2012-02-08T03:23:00+00:00 https://www.pharmaceutical-business-review.com/news/sgi-neb-sign-licensing-agreement-for-gibson-assembly-master-mix-080212/ 2012-02-08T03:27:00+00:00 https://www.pharmaceutical-business-review.com/news/alexion-takes-over-enobia-080212/ 2012-02-08T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/amicus-receives-grant-for-pompe-disease-program-080212/ 2012-02-08T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/biocept-clarient-launch-new-breast-cancer-ctc-test-080212/ 2012-02-08T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/cryostem-completes-stem-cell-processing-for-personal-cell-sciences-080212/ 2012-02-08T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-pertuzumab-drug-gets-fda-priority-review-080212/ 2012-02-08T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/intellect-files-patent-applications-for-new-immunotherapy-approaches-080212/ 2012-02-08T06:07:00+00:00 https://www.pharmaceutical-business-review.com/news/puramed-initiates-clinical-study-of-lipigesic-m-080212/ 2012-02-08T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-signs-licensing-deal-with-bend-research-090212/ 2012-02-09T00:02:00+00:00 https://www.pharmaceutical-business-review.com/news/apotex-pays-sanofi-bristol-damages-over-plavix-090212/ 2012-02-09T00:13:00+00:00 https://www.pharmaceutical-business-review.com/news/app-to-launch-imipenem-and-clilastatin-meropenen-in-us-090212/ 2012-02-09T00:57:00+00:00 https://www.pharmaceutical-business-review.com/news/model-n-releases-revenue-management-solutions-for-life-science-industry-090212/ 2012-02-09T00:57:00+00:00 https://www.pharmaceutical-business-review.com/news/avanir-avp-923-shows-safety-and-efficacy-results-090212/ 2012-02-09T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/inergetics-launches-new-rtd-sports-nutrition-formula-090212/ 2012-02-09T01:14:00+00:00 https://www.pharmaceutical-business-review.com/news/metagenics-releases-phytomulti-supplement-with-iron-090212/ 2012-02-09T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/mit-inr-collaborate-for-strontium-82-production-090212/ 2012-02-09T01:24:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-uk-introduces-generic-glaucoma-drops-090212/ 2012-02-09T03:36:00+00:00 https://www.pharmaceutical-business-review.com/news/navidea-opens-business-commercial-development-office-in-massachusetts-090212/ 2012-02-09T03:42:00+00:00 https://www.pharmaceutical-business-review.com/news/apothecary-to-distribute-pfizer-inlyta-drug/ 2012-02-09T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-launches-medivir-cold-sore-otc-product-in-europe-090212/ 2012-02-09T04:43:00+00:00 https://www.pharmaceutical-business-review.com/news/inviragen-abl-sign-contract-manufacturing-agreement-090212/ 2012-02-09T04:49:00+00:00 https://www.pharmaceutical-business-review.com/news/labec-expands-incelldx-hpv-oncotect-assay-throughout-europe-090212/ 2012-02-09T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/globeimmune-initiates-phase-i-trial-of-gi-6301-090212/ 2012-02-09T06:24:00+00:00 https://www.pharmaceutical-business-review.com/news/mrf-joins-endece-to-develop-treatment-for-multiple-sclerosis-090212/ 2012-02-09T06:52:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-janssen-settle-ortho-tri-cyclen-lo-patent-litigation-090212/ 2012-02-09T06:54:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-doxycycline-hyclate-tablets-win-fda-anda-approval-100212/ 2012-02-09T23:58:00+00:00 https://www.pharmaceutical-business-review.com/news/zalicus-hydra-to-advance-novel-ion-channel-product-candidates-for-pain-therapy-100212/ 2012-02-10T00:01:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-to-open-new-development-center-in-china-100212/ 2012-02-10T00:16:00+00:00 https://www.pharmaceutical-business-review.com/news/jubilant-endo-reach-early-stage-milestones-in-research-collaboration-100212/ 2012-02-10T00:22:00+00:00 https://www.pharmaceutical-business-review.com/news/forest-gedeon-report-positive-phase-iii-bipolar-i-disorder-trial-data-100212/ 2012-02-10T00:39:00+00:00 https://www.pharmaceutical-business-review.com/news/stayinfront-expands-services-contract-with-biotechnology-firm-100212/ 2012-02-10T00:55:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-mobius-glaucoma-drug-100212/ 2012-02-10T01:56:00+00:00 https://www.pharmaceutical-business-review.com/news/altheos-begins-patient-dosing-in-glaucoma-drug-trial-100212/ 2012-02-10T03:13:00+00:00 https://www.pharmaceutical-business-review.com/news/catalyst-files-us-provisional-patent-application-for-gaba-aminotransferase-inhibitors-100212/ 2012-02-10T03:36:00+00:00 https://www.pharmaceutical-business-review.com/news/optinose-enrolls-first-patient-in-phase-iii-intranasal-technology-trial-100212/ 2012-02-10T03:40:00+00:00 https://www.pharmaceutical-business-review.com/news/ppd-forges-research-alliance-with-nrs-100212/ 2012-02-10T03:48:00+00:00 https://www.pharmaceutical-business-review.com/news/biosante-libigel-study-needs-no-modification-says-dmc-100212/ 2012-02-10T04:43:00+00:00 https://www.pharmaceutical-business-review.com/news/branham-investigates-pfizer-for-packaging-error-recall-100212/ 2012-02-10T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/genmab-achieves-second-pre-clinical-milestone-in-lundbeck-collaboration-100212/ 2012-02-10T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/rock-creek-begins-anatabloc-formulation-trial-100212/ 2012-02-10T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/avi-biopharma-reports-data-from-avi-6002-avi-6003-trials-100212/ 2012-02-10T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/sigma-aldrich-posts-15-rise-in-q4-net-profit-100212/ 2012-02-10T06:12:00+00:00 https://www.pharmaceutical-business-review.com/news/tekmira-wins-us-patent-lnp-formulations-mitigation-of-immune-stimulation-100212/ 2012-02-10T06:33:00+00:00 https://www.pharmaceutical-business-review.com/news/titan-announces-positive-results-from-re-treatment-study-of-probuphine-100212/ 2012-02-10T06:37:00+00:00 https://www.pharmaceutical-business-review.com/news/process-seals-develops-aseptic-hygienic-usit-washer-150212/ 2012-02-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-nodality-sign-multi-year-research-collaboration-130212/ 2012-02-12T23:43:00+00:00 https://www.pharmaceutical-business-review.com/news/saint-annes-wins-grant-to-adopt-electronic-health-record-system-130212/ 2012-02-12T23:59:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-files-suit-against-watson-over-birth-control-pill-patent-130212/ 2012-02-13T00:04:00+00:00 https://www.pharmaceutical-business-review.com/news/hikal-to-begin-api-manufacturing-facility-operations-by-june-2012-130212/ 2012-02-13T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/insmed-plans-to-begin-arikace-study-this-year-130212/ 2012-02-13T01:27:00+00:00 https://www.pharmaceutical-business-review.com/news/quintiles-launches-strategic-drug-development-and-consulting-services-130212/ 2012-02-13T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/regeneca-recalls-specific-lot-of-regenarouse-130212/ 2012-02-13T03:51:00+00:00 https://www.pharmaceutical-business-review.com/news/silence-therapeutics-appoints-tony-sedgwick-as-new-ceo-130212/ 2012-02-13T03:54:00+00:00 https://www.pharmaceutical-business-review.com/news/soligenix-announces-encouraging-phase-12-acute-radiation-enteritis-trial-data-130212/ 2012-02-13T04:07:00+00:00 https://www.pharmaceutical-business-review.com/news/santarus-begins-patient-enrollment-in-uceris-drug-trial-130212/ 2012-02-13T04:10:00+00:00 https://www.pharmaceutical-business-review.com/news/vernalis-tris-pharma-sign-exclusive-licensing-agreement-130212/ 2012-02-13T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/almac-launches-metabolite-synthesis-within-selectazyme-service-offering-130212/ 2012-02-13T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/south-africa-to-construct-new-pharmaceutical-plant-130212/ 2012-02-13T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/agnity-launches-new-communications-technology-solution-for-healthcare-130212/ 2012-02-13T17:59:00+00:00 https://www.pharmaceutical-business-review.com/news/pacific-upgrades-pacbio-rs-dna-sequencing-system-chemistry-and-software-140212/ 2012-02-13T18:02:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-takes-over-inhibitex/ 2012-02-14T00:26:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-for-gilead-hiv-drug-140212/ 2012-02-14T00:29:00+00:00 https://www.pharmaceutical-business-review.com/news/amylin-alkermes-announce-availability-of-bydureon-in-us-140212/ 2012-02-14T01:19:00+00:00 https://www.pharmaceutical-business-review.com/news/tianyin-initiates-new-qionglai-facility-construction-140212/ 2012-02-14T01:22:00+00:00 https://www.pharmaceutical-business-review.com/news/celsion-enrolls-first-patient-in-thermodox-plus-rfa-study-140212/ 2012-02-14T03:03:00+00:00 https://www.pharmaceutical-business-review.com/news/tiltan-pharma-initiates-phase-2-study-of-cancer-drug-140212/ 2012-02-14T03:08:00+00:00 https://www.pharmaceutical-business-review.com/news/columbia-transfers-progesterone-vaginal-gel-nda-to-watson-140212/ 2012-02-14T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/medicago-earns-fourth-milestone-payment-from-darpa-140212/ 2012-02-14T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/oncopep-signs-license-agreement-with-dana-farber-for-cancer-vaccine-technology-140212/ 2012-02-14T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/oncosec-initiates-phase-ii-merkel-cell-carcinoma-trial-140212/ 2012-02-14T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/regeneca-commences-manufacturing-of-regenerect-150212/ 2012-02-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-introduces-generic-donepezil-film-coated-and-donepezil-orodispersible-tablets-150212/ 2012-02-14T23:36:00+00:00 https://www.pharmaceutical-business-review.com/news/aicuris-letermovir-trial-meets-primary-efficacy-endpoints-150212/ 2012-02-14T23:53:00+00:00 https://www.pharmaceutical-business-review.com/news/botanical-laboratories-to-launch-gluten-free-line-of-liquid-dietary-supplements-150212/ 2012-02-15T00:29:00+00:00 https://www.pharmaceutical-business-review.com/news/nouveau-life-to-develop-natural-product-for-fsd-150212/ 2012-02-15T00:31:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-includes-new-manufacturing-site-to-duexis-maa-150212/ 2012-02-15T00:40:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-to-purchase-eyetech-150212/ 2012-02-15T00:53:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-receives-fda-approval-for-prostaglandin-analog-ophthalmic-solution-150212/ 2012-02-15T00:56:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-increases-production-of-preservative-free-methotrexate-injection-150212/ 2012-02-15T03:25:00+00:00 https://www.pharmaceutical-business-review.com/news/oragenics-lpt3-04-found-to-reduce-body-weight-150212/ 2012-02-15T03:30:00+00:00 https://www.pharmaceutical-business-review.com/news/trimel-announces-positive-tbs-2-phase-ii-vibrotactile-stimulation-study-data-150212/ 2012-02-15T03:35:00+00:00 https://www.pharmaceutical-business-review.com/news/galena-biopharma-begins-phase-12-study-of-fbp-vaccine-150212/ 2012-02-15T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-seeks-45bn-budget-to-protect-and-promote-public-health-150212/ 2012-02-15T04:53:00+00:00 https://www.pharmaceutical-business-review.com/news/prolor-reports-positive-data-of-hemophilia-drug-150212/ 2012-02-15T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/compugroup-releases-new-cloud-based-lab-connectivity-software-160212/ 2012-02-15T23:16:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-pfizer-tafamidis-meglumine-new-drug-application-160212/ 2012-02-15T23:50:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-supera-farma-partner-to-commercialize-generics-in-brazil-160212/ 2012-02-15T23:55:00+00:00 https://www.pharmaceutical-business-review.com/news/health-management-hospitals-to-deploy-mckesson-pharmacy-automation-solutions-160212/ 2012-02-16T00:06:00+00:00 https://www.pharmaceutical-business-review.com/news/ariad-receives-us-patent-for-ponatinib-pan-bcr-abl-inhibitor-160212/ 2012-02-16T00:55:00+00:00 https://www.pharmaceutical-business-review.com/news/gen-probe-receives-fda-approval-for-progensa-pca3-assay-160212/ 2012-02-16T00:57:00+00:00 https://www.pharmaceutical-business-review.com/news/iric-uses-roche-xcelligence-sp-instrument-in-drug-induced-cellular-activity-study-160212/ 2012-02-16T01:02:00+00:00 https://www.pharmaceutical-business-review.com/news/biosante-wins-fda-nod-for-testosterone-gel-160212/ 2012-02-16T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/afc-continues-investing-in-quality-systems-160212/ 2012-02-16T04:22:00+00:00 https://www.pharmaceutical-business-review.com/news/arno-enters-into-licensing-agreement-with-invivis-160212/ 2012-02-16T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/asymchem-invests-in-dunhua-manufacturing-facility-160212/ 2012-02-16T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/evotek-ir-pharma-enter-drug-discovery-alliance-160212/ 2012-02-16T04:49:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-receives-approval-for-secondary-supplier-of-methoxsalen-160212/ 2012-02-16T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/zoommed-signs-software-development-deal-with-sharpe-medical-170212/ 2012-02-16T22:58:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-pfizer-settle-epinephrine-auto-injector-patent-litigation-with-sanofi-170212/ 2012-02-16T23:41:00+00:00 https://www.pharmaceutical-business-review.com/news/dara-signs-commercialization-agreement-with-uman-pharma-for-anticancer-agent-170212/ 2012-02-17T00:19:00+00:00 https://www.pharmaceutical-business-review.com/news/bedford-recalls-three-lots-of-cytarabine-injection-170212/ 2012-02-17T00:45:00+00:00 https://www.pharmaceutical-business-review.com/news/redhill-biopharma-to-conduct-ondansetron-bioequivalence-trial-170212/ 2012-02-17T00:50:00+00:00 https://www.pharmaceutical-business-review.com/news/xenogenics-gains-rights-to-drug-delivery-patent-from-rutgers-university-170212/ 2012-02-17T00:55:00+00:00 https://www.pharmaceutical-business-review.com/news/us-hospitals-deploy-netsmart-ehr-solution-170212/ 2012-02-17T01:37:00+00:00 https://www.pharmaceutical-business-review.com/news/mjff-funds-neurophage-for-parkinsons-disease-research-170212/ 2012-02-17T03:54:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-rename-dey-pharma-to-mylan-specialty-170212/ 2012-02-17T04:02:00+00:00 https://www.pharmaceutical-business-review.com/news/nccn-partners-with-aveo-astellas-for-oncology-research-170212/ 2012-02-17T04:06:00+00:00 https://www.pharmaceutical-business-review.com/news/scolr-introduces-new-line-of-extended-release-nutritionalvitamin-products-170212/ 2012-02-17T04:14:00+00:00 https://www.pharmaceutical-business-review.com/news/tetraphase-receives-barda-contract-to-develop-new-antibiotic-170212/ 2012-02-17T06:31:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-corcept-korlym-oral-medicine-200212/ 2012-02-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/irbm-signs-licensing-contract-with-dotmatics-200212/ 2012-02-19T20:15:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-zhejiang-to-establish-new-jv-for-generic-medicines-200212/ 2012-02-20T00:16:00+00:00 https://www.pharmaceutical-business-review.com/news/mcneil-recalls-infants-tylenol-oral-suspension-in-us-200212/ 2012-02-20T01:46:00+00:00 https://www.pharmaceutical-business-review.com/news/medistem-shanghai-jia-to-develop-erc-for-critical-limb-ischemia-200212/ 2012-02-20T01:47:00+00:00 https://www.pharmaceutical-business-review.com/news/par-pharmaceutical-takes-over-edict-pharmaceuticals-200212/ 2012-02-20T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/asuragen-launches-mirinform-pancreas-test-200212/ 2012-02-20T04:02:00+00:00 https://www.pharmaceutical-business-review.com/news/catalent-takes-over-aptuit-clinical-trial-supplies-business-200212/ 2012-02-20T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/dainippon-wins-manufacturing-approval-for-sleep-inducing-therapy-in-japan-200212/ 2012-02-20T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/tricore-selects-4medica-iehr-for-patient-data-integration-210212/ 2012-02-20T21:01:00+00:00 https://www.pharmaceutical-business-review.com/news/hospira-to-add-second-supplier-to-increase-methotrexate-supply-210212/ 2012-02-20T23:54:00+00:00 https://www.pharmaceutical-business-review.com/news/sandoz-suspends-drug-production-at-quebec-facility-210212/ 2012-02-21T00:00:00+00:00 https://www.pharmaceutical-business-review.com/news/dako-amgen-to-develop-new-diagnostic-test-for-cancer-therapy-210212/ 2012-02-21T01:02:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-phase-iii-trial-of-vedolizumab-meets-primary-endpoints-210212/ 2012-02-21T02:28:00+00:00 https://www.pharmaceutical-business-review.com/news/plexxikon-receives-european-approval-for-zelboraf-210212/ 2012-02-21T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/precision-files-two-patent-infringement-lawsuits-against-cellectis-210212/ 2012-02-21T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/ranbaxy-launches-cholesterol-reducing-drug-in-australia-210212/ 2012-02-21T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/txcell-reports-positive-immuno-monitoring-results-from-phase-iii-crohns-disease-study-210212/ 2012-02-21T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/jubilant-biosys-mnemosyne-enter-into-research-collaboration-220212/ 2012-02-21T23:57:00+00:00 https://www.pharmaceutical-business-review.com/news/enanta-signs-licensing-contract-with-novartis-for-hepatitis-c-drug-220212/ 2012-02-22T00:00:00+00:00 https://www.pharmaceutical-business-review.com/news/ninesigma-iavi-partner-to-advance-hiv-vaccine-research-220212/ 2012-02-22T00:03:00+00:00 https://www.pharmaceutical-business-review.com/news/actelion-gains-commercialization-rights-to-tesamorelin-in-canada-220212/ 2012-02-22T01:44:00+00:00 https://www.pharmaceutical-business-review.com/news/asymchem-plans-additional-investment-in-dunhua-manufacturing-facility-220212/ 2012-02-22T01:46:00+00:00 https://www.pharmaceutical-business-review.com/news/reliv-receives-us-patent-for-blood-sugar-management-supplement-220212/ 2012-02-22T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-to-update-high-blood-pressure-drug-label-220212/ 2012-02-22T02:38:00+00:00 https://www.pharmaceutical-business-review.com/news/app-pharmaceuticals-receives-marketing-approval-for-methotrexate-injection-220212/ 2012-02-22T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/acella-files-anda-with-fda-for-respiratory-therapeutic-agent-220212/ 2012-02-22T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designation-to-arno-cns-drug-220212/ 2012-02-22T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/study-detects-c-peptide-production-in-diabetes-patients-decades-after-disease-onset-220212/ 2012-02-22T04:50:00+00:00 https://www.pharmaceutical-business-review.com/news/enzo-biochem-wins-approval-for-colonsentry-rna-expression-assay-220212/ 2012-02-22T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/ophthalix-receives-chinese-patent-for-treatment-of-dry-eye-disorders-220212/ 2012-02-22T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/proactivelife-launches-new-diabetes-support-supplement-220212/ 2012-02-22T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/xencor-boehringer-collaborate-to-develop-biosuperior-monoclonal-antibodies-220212/ 2012-02-22T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/concentra-deploys-allscripts-ehr-system-230212/ 2012-02-22T19:46:00+00:00 https://www.pharmaceutical-business-review.com/news/siemens-healthcare-introduces-two-new-cloud-based-solutions-230212/ 2012-02-22T22:35:00+00:00 https://www.pharmaceutical-business-review.com/news/american-regent-recalls-phenylephrine-hcl-injection-230212/ 2012-02-22T23:54:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-approves-shire-vpriv-manufacturing-facility-230212/ 2012-02-22T23:56:00+00:00 https://www.pharmaceutical-business-review.com/news/apceth-indivumed-to-develop-tissue-based-biomarker-strategy-230212/ 2012-02-23T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/omeros-receives-nida-grant-for-nmur2-drug-development-program-230212/ 2012-02-23T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/onyx-completes-enrollment-in-phase-iii-relapsed-multiple-myeloma-trial-230212/ 2012-02-23T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/santarus-depomed-settle-glumetza-patent-litigation-with-lupin-230212/ 2012-02-23T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/health-mart-launches-vitamins-nutritional-supplements-230212/ 2012-02-23T03:51:00+00:00 https://www.pharmaceutical-business-review.com/news/marina-receives-noa-for-smarticles-delivery-technology-patent-230212/ 2012-02-23T03:57:00+00:00 https://www.pharmaceutical-business-review.com/news/nanosonic-signs-trappsol-cyclo-manufacturing-agreement-with-biologix-230212/ 2012-02-23T04:00:00+00:00 https://www.pharmaceutical-business-review.com/news/novelos-initiates-phase-1-2-pet-imaging-trial-230212/ 2012-02-23T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/eurogentec-drug-substance-manufacturing-facility-wins-fda-nod-230212/ 2012-02-23T07:48:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-advisory-committee-recommends-vivus-obesity-drug-230212/ 2012-02-23T07:50:00+00:00 https://www.pharmaceutical-business-review.com/news/paladin-files-nds-for-insomnia-drug-in-canada-230212/ 2012-02-23T07:52:00+00:00 https://www.pharmaceutical-business-review.com/news/phasebio-begins-phase-i-hypertension-study-with-vasomera-230212/ 2012-02-23T07:58:00+00:00 https://www.pharmaceutical-business-review.com/news/isoft-southampton-nhs-foundation-trust-partner-for-life-science-project-240212/ 2012-02-23T22:30:00+00:00 https://www.pharmaceutical-business-review.com/news/auxilium-actelion-sign-commercialization-agreement-for-xiaflex-240212/ 2012-02-23T23:46:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-accepts-genzyme-maa-of-multiple-sclerosis-drug-240212/ 2012-02-24T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-advisory-committee-recommends-chelsea-neurogenic-oh-drug-approval-240212/ 2012-02-24T01:00:00+00:00 https://www.pharmaceutical-business-review.com/news/galen-acquires-daunorubicin-citrate-liposome-injection-from-gilead-240212/ 2012-02-24T01:03:00+00:00 https://www.pharmaceutical-business-review.com/news/can-fite-receives-orphan-drug-status-for-anti-cancer-agent-240212/ 2012-02-24T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-receives-tentative-fda-approval-for-abacavir-sulfate-and-lamivudine-tablets-240212/ 2012-02-24T01:06:00+00:00 https://www.pharmaceutical-business-review.com/news/sirona-reports-positive-preclinical-results-of-diabetes-compound-240212/ 2012-02-24T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/pra-opens-new-office-in-singapore-240212/ 2012-02-24T04:32:00+00:00 https://www.pharmaceutical-business-review.com/news/vertex-reports-interim-data-from-phase-ii-zenith-study-240212/ 2012-02-24T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-terumo-to-co-develop-intradermal-vaccine-280212/ 2012-02-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-reports-positive-phase-iii-affirm-study-results-with-mdv3100-270212/ 2012-02-26T23:41:00+00:00 https://www.pharmaceutical-business-review.com/news/forest-laboratories-gains-european-approval-for-colobreathe-dry-powder-inhaler-270212/ 2012-02-27T00:13:00+00:00 https://www.pharmaceutical-business-review.com/news/glenmark-recalls-seven-lots-of-norgestimate-and-ethinyl-estradiol-tablets-270212/ 2012-02-27T00:16:00+00:00 https://www.pharmaceutical-business-review.com/news/regeneca-recalls-all-lots-of-single-capsule-packet-regenerect-270212/ 2012-02-27T00:20:00+00:00 https://www.pharmaceutical-business-review.com/news/rhei-wins-marketing-approval-for-mugard-in-china-270212/ 2012-02-27T00:30:00+00:00 https://www.pharmaceutical-business-review.com/news/visiopharm-launches-appsolute-digital-pathology-solution-270212/ 2012-02-27T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/angiochem-gsk-to-discover-therapies-for-lysosomal-storage-diseases-270212/ 2012-02-27T03:35:00+00:00 https://www.pharmaceutical-business-review.com/news/csl-screens-first-patient-in-phase-iiii-recombinant-single-chain-factor-viii-study-270212/ 2012-02-27T03:53:00+00:00 https://www.pharmaceutical-business-review.com/news/app-grand-island-plant-gets-warning-letter-270212/ 2012-02-27T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/jubilant-wins-parenteral-product-manufacturing-contracts-270212/ 2012-02-27T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/rvc-biofund-quintiles-to-expand-clinical-development-services/ 2012-02-27T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/tak-875-improves-glycemic-control-in-diabetic-patients-270212/ 2012-02-27T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-announces-three-year-protein-engineering-agreement-270212/ 2012-02-27T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/nouveau-expands-azul-instant-into-puerto-rico-market-280212/ 2012-02-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/affymax-to-receive-development-milestone-payment-from-takeda-280212/ 2012-02-27T23:45:00+00:00 https://www.pharmaceutical-business-review.com/news/emd-millipore-opens-new-lab-water-production-site-in-china-280212/ 2012-02-27T23:47:00+00:00 https://www.pharmaceutical-business-review.com/news/indel-receives-us-patent-for-antimicrobial-targeting-paradigm-280212/ 2012-02-27T23:52:00+00:00 https://www.pharmaceutical-business-review.com/news/nepal-drugs-to-restart-operations-280212/ 2012-02-28T00:02:00+00:00 https://www.pharmaceutical-business-review.com/news/british-columbia-to-deal-with-drug-shortages-280212/ 2012-02-28T00:04:00+00:00 https://www.pharmaceutical-business-review.com/news/allergease-unveils-herbal-lozenge-for-allergy-sufferers-280212/ 2012-02-28T00:06:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-takes-over-alacer-280212/ 2012-02-28T03:24:00+00:00 https://www.pharmaceutical-business-review.com/news/selventa-signs-research-agreement-with-janssen-280212/ 2012-02-28T03:30:00+00:00 https://www.pharmaceutical-business-review.com/news/emd-millipore-charles-river-sign-licensing-contract-280212/ 2012-02-28T03:54:00+00:00 https://www.pharmaceutical-business-review.com/news/ikaria-completes-patient-enrollment-in-phase-iii-trial-of-inomax-280212/ 2012-02-28T04:05:00+00:00 https://www.pharmaceutical-business-review.com/news/cannabis-science-to-launch-new-product-line-280212/ 2012-02-28T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/octapharma-submits-bla-for-octaplaslg-280212/ 2012-02-28T06:24:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-meridian-tru-legionella-test-290212/ 2012-02-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/agilent-bgi-to-develop-new-methodologies-for-disease-and-drug-research-290212/ 2012-02-28T23:45:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-dtmi-establish-strategic-research-partnership-290212/ 2012-02-28T23:52:00+00:00 https://www.pharmaceutical-business-review.com/news/biostorage-includes-sample-preparation-services-into-european-operations-290212/ 2012-02-28T23:55:00+00:00 https://www.pharmaceutical-business-review.com/news/rite-aid-selects-capturerx-to-offer-340b-contract-pharmacy-services-290212/ 2012-02-29T00:13:00+00:00 https://www.pharmaceutical-business-review.com/news/amarin-selects-bioclinica-eclinical-suite-290212/ 2012-02-29T00:13:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-deploys-revitas-strategic-flex-technology-platform-290212/ 2012-02-29T00:33:00+00:00 https://www.pharmaceutical-business-review.com/news/cumberland-signs-licensing-deal-for-acetadote-and-caldolor-in-china-290212/ 2012-02-29T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/florida-biologix-to-formulate-fill-nanosonic-trappsol-cyclo-290212/ 2012-02-29T03:04:00+00:00 https://www.pharmaceutical-business-review.com/news/akorn-purchases-certain-assets-of-kilitch-drugs-india-290212/ 2012-02-29T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/domp-to-acquire-italian-ophthalmology-company-290212/ 2012-02-29T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-tau-ind-for-mibefradil-290212/ 2012-02-29T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-eclipse-enter-et-101-production-deal-290212/ 2012-02-29T06:07:00+00:00 https://www.pharmaceutical-business-review.com/news/oncosec-initiates-phase-ii-metastatic-melanoma-trial-290212/ 2012-02-29T08:01:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-biogen-idec-avonex-im-injector-290212/ 2012-02-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-generic-version-of-lexapro-tablets-010312/ 2012-03-01T00:00:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-galapagos-to-develop-rheumatoid-arthritis-therapy-010312/ 2012-03-01T01:44:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-medimmune-four-strain-flu-vaccine-010312/ 2012-03-01T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/hi-tech-pharmacal-receives-fda-nod-for-levetiracetam-oral-solution-010312/ 2012-03-01T03:46:00+00:00 https://www.pharmaceutical-business-review.com/news/jhp-pharmaceuticals-signs-multi-year-manufacturing-contract-010312/ 2012-03-01T03:49:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-receives-fda-approval-for-lower-dose-formulation-of-angeliq-010312/ 2012-03-01T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/immunocellular-jhu-sign-licensing-contract-for-mesothelin-cancer-antigen-010312/ 2012-03-01T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/argen-x-shire-strike-therapeutic-antibody-alliance-010312/ 2012-03-01T04:50:00+00:00 https://www.pharmaceutical-business-review.com/news/opexa-signs-service-agreement-with-pharmaceutical-research-associates-010312/ 2012-03-01T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/avanir-concert-sign-licensing-contract-for-deuterium-modified-dextromethorphan-010312/ 2012-03-01T07:04:00+00:00 https://www.pharmaceutical-business-review.com/news/eyegate-pharma-begins-egp-437-drug-trial-010312/ 2012-03-01T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/islet-sciences-to-take-over-diakine-therapeutics-010312/ 2012-03-01T07:11:00+00:00 https://www.pharmaceutical-business-review.com/news/omkar-speciality-chemicals-to-purchase-lasa-laboratory-010312/ 2012-03-01T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/trianz-launches-new-version-of-acceliant-eclinical-suite-v64-020312/ 2012-03-01T19:51:00+00:00 https://www.pharmaceutical-business-review.com/news/cheminnova-forms-equity-based-joint-venture-with-rapid-nutrition-020312/ 2012-03-01T23:13:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-framingham-plant-initiates-shipment-of-fabrazyme-drug-020312/ 2012-03-02T00:37:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-aptalis-ultresa-viokace-formulations-020312/ 2012-03-02T00:40:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-to-invest-270m-in-ohio-nutrition-manufacturing-facility-020312/ 2012-03-02T00:42:00+00:00 https://www.pharmaceutical-business-review.com/news/tekmira-develops-new-rnai-therapeutic-to-treat-alcohol-dependence-020312/ 2012-03-02T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/ventana-gains-approval-for-inform-her2-dual-ish-assay-020312/ 2012-03-02T03:41:00+00:00 https://www.pharmaceutical-business-review.com/news/nymox-commences-phase-2-study-of-prostate-cancer-drug-020312/ 2012-03-02T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-actemra-drug-shows-superiority-over-adalimumab-020312/ 2012-03-02T06:12:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-secures-milestone-payment-in-osteoarthritis-alliance-020312/ 2012-03-02T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/cambridge-biomedical-deploys-qumas-compliance-platform-020312/ 2012-03-04T18:09:00+00:00 https://www.pharmaceutical-business-review.com/news/therapeuticsmd-introduces-prescription-prenatal-vitamin-050312/ 2012-03-04T23:08:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-introduces-generic-version-of-geodon-in-us-050312/ 2012-03-04T23:42:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-daiichi-sankyo-establish-new-vaccine-jv-in-japan-050312/ 2012-03-04T23:49:00+00:00 https://www.pharmaceutical-business-review.com/news/app-pharmaceuticals-expands-methotrexate-injection-supply-050312/ 2012-03-05T00:49:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-wins-european-marketing-authorization-for-vepacel-050312/ 2012-03-05T00:54:00+00:00 https://www.pharmaceutical-business-review.com/news/south-korean-government-funds-sk-biopharmaceuticals-epilepsy-drug-program-050312/ 2012-03-05T00:57:00+00:00 https://www.pharmaceutical-business-review.com/news/acura-nexafed-disrupts-conversion-of-pseudoephedrine-into-methamphetamine-050312/ 2012-03-05T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/bioinvent-genentech-complete-patient-enrollment-in-bi-204-study-050312/ 2012-03-05T04:26:00+00:00 https://www.pharmaceutical-business-review.com/news/rubicon-genomics-selects-velesco-to-manufacture-transplex-kits-050312/ 2012-03-05T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/tg-therapeutics-signs-licensing-agreement-with-lfb-for-ublituximab-050312/ 2012-03-05T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/giant-sports-introduces-new-sports-nutrition-supplement-050312/ 2012-03-05T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/novavax-initiates-phase-ii-influenza-vaccine-trial-050312/ 2012-03-05T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/eclinso-xclinical-strike-partnership-agreement-050312/ 2012-03-05T18:12:00+00:00 https://www.pharmaceutical-business-review.com/news/concert-pharma-joins-fast-forward-to-advance-ms-drug-070312/ 2012-03-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/grnenthal-adopts-bioclinica-onpoint-ctms-technology-060312/ 2012-03-05T20:19:00+00:00 https://www.pharmaceutical-business-review.com/news/twinlab-rolls-out-bariatric-support-supplement-line-060312/ 2012-03-05T20:24:00+00:00 https://www.pharmaceutical-business-review.com/news/tls-signs-licensing-contract-with-stanford-university-060312/ 2012-03-05T23:46:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-unveils-generic-version-of-prometrium-capsules-060312/ 2012-03-05T23:52:00+00:00 https://www.pharmaceutical-business-review.com/news/new-study-shows-benefits-of-green-tea-gallate-extract-in-treating-diabetes-060312/ 2012-03-05T23:56:00+00:00 https://www.pharmaceutical-business-review.com/news/medicyte-primacyt-receive-bmbf-grant-to-develop-human-liver-cells-060312/ 2012-03-06T01:50:00+00:00 https://www.pharmaceutical-business-review.com/news/penn-pharma-announces-14m-investment-in-south-wales-uk-facility-060312/ 2012-03-06T01:52:00+00:00 https://www.pharmaceutical-business-review.com/news/biolife-solutions-to-build-second-gmp-production-facility-060312/ 2012-03-06T05:18:00+00:00 https://www.pharmaceutical-business-review.com/news/biolinerx-receives-israeli-approval-for-commencing-phase-ii-clinical-trial-of-bl-7040-060312/ 2012-03-06T05:22:00+00:00 https://www.pharmaceutical-business-review.com/news/unigene-to-support-stealths-phase-1-study-for-drug-candidates-060312/ 2012-03-06T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/medicago-mitsubishi-tanabe-to-jointly-develop-vaccines-070312/ 2012-03-06T23:55:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-initiates-trials-to-compare-vyvanse-with-concerta-in-adhd-treatment-070312/ 2012-03-06T23:58:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-grants-ck-2017357-orphan-medicinal-product-designation-070312/ 2012-03-07T00:00:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-receives-fdas-complete-response-letter-for-dacogen-070312/ 2012-03-07T01:45:00+00:00 https://www.pharmaceutical-business-review.com/news/eyescience-develops-new-eye-vitamin-for-diabetes-patients-070312/ 2012-03-07T01:47:00+00:00 https://www.pharmaceutical-business-review.com/news/marshall-edwards-submits-ind-application-to-fda-070312/ 2012-03-07T02:00:00+00:00 https://www.pharmaceutical-business-review.com/news/particle-sciences-acquires-exclusive-license-to-lyocell-patent-portfolio-070312/ 2012-03-07T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/amitiza-reports-safety-profile-in-ibs-c-patients-070312/ 2012-03-07T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-discovery-labs-surfaxin-drug-070312/ 2012-03-07T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/vertex-announces-interim-results-from-incivek-phase-2-study-070312/ 2012-03-07T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/herbalife-launches-calcium-supplement-xtra-cal-in-india-080312/ 2012-03-07T21:08:00+00:00 https://www.pharmaceutical-business-review.com/news/sobhan-oncology-production-line-opens-in-rasht-iran-080312/ 2012-03-07T22:40:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-ait-found-to-reduce-ragweed-allergy-symptoms-080312/ 2012-03-07T22:42:00+00:00 https://www.pharmaceutical-business-review.com/news/gansu-duyiwei-signs-deal-to-develop-commercialize-apx004-in-china-080312/ 2012-03-07T22:44:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-drug-signifor-normalized-cortisol-levels-in-cushings-disease-report-080312/ 2012-03-07T22:47:00+00:00 https://www.pharmaceutical-business-review.com/news/jentadueto-tablets-for-type-2-diabetes-treatment-now-available-in-us-080312/ 2012-03-07T22:51:00+00:00 https://www.pharmaceutical-business-review.com/news/aragon-secures-42m-in-series-c-financing-080312/ 2012-03-07T22:52:00+00:00 https://www.pharmaceutical-business-review.com/news/carefusion-signs-deal-to-acquire-phacts-080312/ 2012-03-07T22:53:00+00:00 https://www.pharmaceutical-business-review.com/news/pycnogenol-significantly-improves-signs-and-symptoms-of-menopause-study-080312/ 2012-03-08T01:25:00+00:00 https://www.pharmaceutical-business-review.com/news/almac-pharma-services-expands-packaging-operations-in-us-080312/ 2012-03-08T02:34:00+00:00 https://www.pharmaceutical-business-review.com/news/conformetrix-appoints-sam-williams-as-ceo-080312/ 2012-03-08T02:36:00+00:00 https://www.pharmaceutical-business-review.com/news/rottapharm-madaus-implements-cegedim-crm-to-streamline-operations-090312/ 2012-03-08T18:20:00+00:00 https://www.pharmaceutical-business-review.com/news/ge-healthcare-to-acquire-xcellerex-090312/ 2012-03-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mersanaendo-pharmaceuticals-to-develop-antibody-drug-conjugates-090312/ 2012-03-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/promedior-prm-151-gets-fda-orphan-drug-status-090312/ 2012-03-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-pharma-signs-deal-to-commercialise-lodotra-in-latin-america-090312/ 2012-03-08T21:40:00+00:00 https://www.pharmaceutical-business-review.com/news/european-patent-granted-to-biolinerx-bl-1020-for-schizophrenia-treatment-090312/ 2012-03-08T22:40:00+00:00 https://www.pharmaceutical-business-review.com/news/chronix-biomedical-opens-sequencing-lab-in-brookings-090312/ 2012-03-08T23:35:00+00:00 https://www.pharmaceutical-business-review.com/news/revitas-validata-solution-helps-reduce-pharma-companies-margin-erosion-090312/ 2012-03-08T23:58:00+00:00 https://www.pharmaceutical-business-review.com/news/cytheris-reports-encouraging-results-from-of-phase-ii-hiv-study-090312/ 2012-03-09T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/circassia-reports-positive-results-from-phase-ii-ragweed-allergy-therapy-study-090312/ 2012-03-09T04:32:00+00:00 https://www.pharmaceutical-business-review.com/news/study-finds-potential-of-stem-cells-in-regenerating-damaged-heart-tissue-090312/ 2012-03-09T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-unblinds-phase-3-study-of-zytiga-on-idmc-recommendation-090312/ 2012-03-09T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/rusnano-domain-to-invest-760m-in-drug-production-facility-090312/ 2012-03-09T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-eylea-injection-gets-australian-clearance-090312/ 2012-03-09T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/vita-logic-launches-new-herbal-supplements-130312/ 2012-03-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/medrevenu-adopts-medinformatix-billingclaims-solution-120312/ 2012-03-11T21:17:00+00:00 https://www.pharmaceutical-business-review.com/news/boca-pharmacal-receives-fda-approval-for-methimazole-tablets-120312/ 2012-03-11T23:59:00+00:00 https://www.pharmaceutical-business-review.com/news/elis-pharma-to-present-erectile-dysfunction-drug-vitaros-in-dubai-event-120312/ 2012-03-12T00:02:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-plans-new-corporate-headquarters-in-pennsylvania-120312/ 2012-03-12T00:03:00+00:00 https://www.pharmaceutical-business-review.com/news/fire-halts-drug-production-at-sandoz-boucherville-plant-120312/ 2012-03-12T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/peregrine-reports-results-from-phase-ii-front-line-lung-cancer-trial-120312/ 2012-03-12T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/virginia-adopts-national-precursor-log-exchange-system-120312/ 2012-03-12T02:16:00+00:00 https://www.pharmaceutical-business-review.com/news/ucbdomainex-collaborate-on-cancer-drug-target-120312/ 2012-03-12T02:50:00+00:00 https://www.pharmaceutical-business-review.com/news/intrepid-cosmo-pharma-to-conduct-cb-03-01-trials-120312/ 2012-03-12T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/plandai-files-crs-hydrodynamic-process-patent-application-120312/ 2012-03-12T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-introduces-generic-naramig-120312/ 2012-03-12T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/lts-nutraceuticals-signs-merger-deal-with-ytb-international-130212/ 2012-03-12T21:28:00+00:00 https://www.pharmaceutical-business-review.com/news/sunpeaks-adds-dakota-drug-as-wholesale-distributor-of-multivitamin-clotamin-130312/ 2012-03-12T23:22:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-commences-us-phase-iii-study-of-esmya-130312/ 2012-03-12T23:42:00+00:00 https://www.pharmaceutical-business-review.com/news/ranbaxy-expands-in-north-africa-opens-new-facility-in-morocco-130312/ 2012-03-13T02:32:00+00:00 https://www.pharmaceutical-business-review.com/news/immunocellular-reports-efficacy-of-ict-107-vaccine-manufacturing-process-130312/ 2012-03-13T03:00:00+00:00 https://www.pharmaceutical-business-review.com/news/dsm-to-commercially-manufacture-talactoferrin-for-agennix-130312/ 2012-03-13T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/immunovaccine-weill-cornell-to-jointly-advance-anti-cocaine-vaccine-130312/ 2012-03-13T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/emd-millipore-collaborates-with-canadian-center-for-stem-cells-cultivation-130312/ 2012-03-13T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/cellceutix-files-pre-ind-submission-with-fda-on-new-psoriasis-drug-130312/ 2012-03-13T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/natco-pharma-wins-license-to-manufacture-sell-nexavar-in-india-130312/ 2012-03-13T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-aradigm-phase-iii-trial-of-pulmaquin-140312/ 2012-03-13T23:21:00+00:00 https://www.pharmaceutical-business-review.com/news/biocon-pfizer-conclude-to-move-forward-independently-140312/ 2012-03-14T00:17:00+00:00 https://www.pharmaceutical-business-review.com/news/biodelivery-postpones-relaunch-of-onsolis-in-us-140312/ 2012-03-14T00:24:00+00:00 https://www.pharmaceutical-business-review.com/news/cortex-gains-two-us-patents-for-ampakine-compounds-140312/ 2012-03-14T00:27:00+00:00 https://www.pharmaceutical-business-review.com/news/epistem-signs-three-year-biomarker-collaboration-with-glaxosmithkline-140312/ 2012-03-14T00:29:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-cornerstone-crtx-080-nda-140312/ 2012-03-14T00:32:00+00:00 https://www.pharmaceutical-business-review.com/news/medicinova-receives-notice-of-japan-patent-allowance-for-ibudilast-140312/ 2012-03-14T00:42:00+00:00 https://www.pharmaceutical-business-review.com/news/psivida-signs-technology-evaluation-agreement-with-neuron-140312/ 2012-03-14T01:59:00+00:00 https://www.pharmaceutical-business-review.com/news/rexahn-initiates-phase-i-cancer-trial-of-rx-3117-140312/ 2012-03-14T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/clariant-offers-mevopur-color-range-for-pharma-packaging-140312/ 2012-03-14T03:18:00+00:00 https://www.pharmaceutical-business-review.com/news/hemaquest-secures-13m-series-b-extension-financing-140312/ 2012-03-14T03:28:00+00:00 https://www.pharmaceutical-business-review.com/news/kerr-drugunc-collaborate-on-pharmacogenetic-program-for-plavix-140312/ 2012-03-14T03:31:00+00:00 https://www.pharmaceutical-business-review.com/news/saladax-signs-distribution-contract-for-my5-fu-in-spain-protugal-140312/ 2012-03-14T03:41:00+00:00 https://www.pharmaceutical-business-review.com/news/pointcross-launches-drug-safety-information-management-suite-150312/ 2012-03-14T17:59:00+00:00 https://www.pharmaceutical-business-review.com/news/recordati-selects-cegedim-relationship-management-crm-solution-150312/ 2012-03-14T18:06:00+00:00 https://www.pharmaceutical-business-review.com/news/cardium-launches-medpodium-nutra-apps-products-in-us-150312/ 2012-03-14T22:33:00+00:00 https://www.pharmaceutical-business-review.com/news/gedeon-richter-spain-deploys-cegedim-mobile-intelligence-solution-150312/ 2012-03-14T23:05:00+00:00 https://www.pharmaceutical-business-review.com/news/effrx-receives-fda-approval-for-osteoporosis-drug-150312/ 2012-03-14T23:06:00+00:00 https://www.pharmaceutical-business-review.com/news/marina-pronai-sign-licensing-contract-for-liposomal-delivery-technology-150312/ 2012-03-14T23:16:00+00:00 https://www.pharmaceutical-business-review.com/news/numerate-enters-into-research-collaboration-with-merck-150312/ 2012-03-14T23:20:00+00:00 https://www.pharmaceutical-business-review.com/news/nycomed-launches-omnaris-nasal-spray-in-uae-150312/ 2012-03-14T23:25:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-launches-generic-lexapro-tablets-150312/ 2012-03-14T23:33:00+00:00 https://www.pharmaceutical-business-review.com/news/aak-launches-new-skin-care-ingredient-150312/ 2012-03-15T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-bayer-hmb-drug-150312/ 2012-03-15T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/oncothyreon-initiates-phase-i-trial-of-ont-10-150312/ 2012-03-15T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/synthetic-biologics-completes-patient-enrollment-in-oral-trimesta-study-150312/ 2012-03-15T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/global-health-brand-selects-calliduscloud-to-enhance-sales-performance-160312/ 2012-03-15T18:25:00+00:00 https://www.pharmaceutical-business-review.com/news/tha-deploys-cegedim-tool-across-its-european-business-units-160312/ 2012-03-15T20:08:00+00:00 https://www.pharmaceutical-business-review.com/news/threshold-initiates-phase-iii-myeloma-trial-160312/ 2012-03-15T23:11:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-rosuvastatin-calcium-tablets-receive-health-canada-approval-160312/ 2012-03-16T00:05:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-initiates-two-phase-3-clinical-trials-on-humira-160312/ 2012-03-16T01:23:00+00:00 https://www.pharmaceutical-business-review.com/news/phase-iii-allegro-study-shows-favorable-results-in-rrms-patients-160312/ 2012-03-16T01:27:00+00:00 https://www.pharmaceutical-business-review.com/news/repligen-enrolls-first-patient-in-rg2833-phase-1-clinical-trial-160312/ 2012-03-16T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sigma-aldrich-unveils-new-distribution-center-packaging-facility-in-india-160312/ 2012-03-16T01:36:00+00:00 https://www.pharmaceutical-business-review.com/news/united-therapeutics-files-patent-infringement-lawsuit-against-sandoz-160312/ 2012-03-16T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/medivector-wins-jpm-tmt-contract-to-develop-influenza-drug-160312/ 2012-03-16T03:56:00+00:00 https://www.pharmaceutical-business-review.com/news/thrombogenics-alcon-strikes-ocriplasmin-marketing-agreement-160312/ 2012-03-16T04:15:00+00:00 https://www.pharmaceutical-business-review.com/news/xtl-signs-strategic-collaboration-framework-agreement-160312/ 2012-03-16T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/biomar-invests-in-api-production-facility-160312/ 2012-03-16T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/cubist-expands-rd-facility-in-us-190312/ 2012-03-18T23:51:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-to-purchase-pluromed-190312/ 2012-03-18T23:56:00+00:00 https://www.pharmaceutical-business-review.com/news/tribute-receives-health-canada-approval-for-acute-migraine-therapy-190312/ 2012-03-19T00:00:00+00:00 https://www.pharmaceutical-business-review.com/news/thrombogenics-signs-commercialization-agreement-with-alcon-190312/ 2012-03-19T01:19:00+00:00 https://www.pharmaceutical-business-review.com/news/zo-skin-health-unveils-new-physician-skincare-line-190312/ 2012-03-19T01:22:00+00:00 https://www.pharmaceutical-business-review.com/news/danadams-pharmaceutical-to-produce-anti-retroviral-drugs-in-ghana-190312/ 2012-03-19T04:12:00+00:00 https://www.pharmaceutical-business-review.com/news/recipharm-to-manufacture-viropharma-plenadren-tablet-190312/ 2012-03-19T04:24:00+00:00 https://www.pharmaceutical-business-review.com/news/threshold-gains-orphan-drug-designation-for-sarcoma-drug-190312/ 2012-03-19T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/biofocus-argenta-enter-drug-discovery-collaboration-with-astrazeneca-190312/ 2012-03-19T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/ge-healthcare-launches-new-bioprocess-affinity-resin-190312/ 2012-03-19T06:33:00+00:00 https://www.pharmaceutical-business-review.com/news/sk-biopharmaceuticals-initiates-phase-ii-chronic-constipation-trial-190312/ 2012-03-19T06:36:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-to-develop-california-institute-for-biomedical-research-190312/ 2012-03-19T06:40:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-speeds-up-drug-review-process-190312/ 2012-03-19T06:44:00+00:00 https://www.pharmaceutical-business-review.com/news/aperio-collaborates-with-dell-to-develop-medical-cloud-network-for-pathology-200312/ 2012-03-19T23:14:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-recommends-change-of-caelyx-and-ceplene-manufacturing-site-200312/ 2012-03-20T00:09:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-to-close-uk-plant-in-2015-200312/ 2012-03-20T00:24:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-government-invests-in-wool-packaging-solutions-to-reduce-vaccine-wastages-200312/ 2012-03-20T01:53:00+00:00 https://www.pharmaceutical-business-review.com/news/avaxia-wins-phase-ii-sbir-grant-to-develop-inflammatory-bowel-disease-therapy-200312/ 2012-03-20T03:28:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-launches-once-daily-bronchodilator-for-copd-200312/ 2012-03-20T03:31:00+00:00 https://www.pharmaceutical-business-review.com/news/cellceutix-signs-collaborative-agreement-with-beth-200312/ 2012-03-20T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/inventive-to-purchase-kforce-clinical-research-200312/ 2012-03-20T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/dbs-launches-automated-ihc-multiplex-platform-for-anatomic-pathology-200312/ 2012-03-20T06:36:00+00:00 https://www.pharmaceutical-business-review.com/news/provectus-reports-positive-top-line-data-from-phase-ii-psoriasis-trial/ 2012-03-20T06:38:00+00:00 https://www.pharmaceutical-business-review.com/news/qrxpharma-enters-into-loa-with-actavis-200312/ 2012-03-20T06:40:00+00:00 https://www.pharmaceutical-business-review.com/news/prolor-begins-phase-ii-trial-of-human-growth-hormone-210312/ 2012-03-20T23:55:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-oxford-university-sign-research-deal-210312/ 2012-03-21T00:13:00+00:00 https://www.pharmaceutical-business-review.com/news/ablynx-boehringer-extend-strategic-nanobody-alliance-210312/ 2012-03-21T00:18:00+00:00 https://www.pharmaceutical-business-review.com/news/uluru-receives-marketing-approval-for-altrazeal-in-new-zealand-210312/ 2012-03-21T01:02:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-targacept-tc-5214-efficacy-studies-fail-to-meet-primary-endpoint/ 2012-03-21T01:19:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-unveils-generic-version-of-boniva-210312/ 2012-03-21T01:22:00+00:00 https://www.pharmaceutical-business-review.com/news/creative-bioscience-introduces-weight-loss-supplements-in-us-210312/ 2012-03-21T01:24:00+00:00 https://www.pharmaceutical-business-review.com/news/lexicon-lx1032-drug-wins-fda-orphan-drug-status-210312/ 2012-03-21T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/meda-gains-european-approval-for-astepro-210312/ 2012-03-21T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/qlt-gets-orphan-drug-designation-for-visudyne-injection-210312/ 2012-03-21T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/xeris-wins-us-patent-for-intracutaneous-injection-210312/ 2012-03-21T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/epigentek-develops-new-microplate-based-method-to-detect-seventh-base-in-dna-210312/ 2012-03-21T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/lorus-receives-canadian-patent-for-anticancer-drug-210312/ 2012-03-21T07:13:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-reaches-milestone-in-research-alliance-with-janssen-220312/ 2012-03-21T23:55:00+00:00 https://www.pharmaceutical-business-review.com/news/probi-signs-distribution-contract-with-usv-in-india-220312/ 2012-03-22T00:02:00+00:00 https://www.pharmaceutical-business-review.com/news/merz-launches-mederma-advanced-scar-gel-220312/ 2012-03-22T00:39:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-signs-licensing-contract-with-heptares-210312/ 2012-03-22T00:46:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-paxvax-oral-cholera-vaccine-ind-application-210312/ 2012-03-22T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/tarsa-enters-into-supply-agreement-with-qs-pharma-220312/ 2012-03-22T03:33:00+00:00 https://www.pharmaceutical-business-review.com/news/medicinova-completes-enrollment-in-phase-ii-asthma-trial-220312/ 2012-03-22T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/particle-pernix-to-develop-new-topical-dermatology-product-220312/ 2012-03-22T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-wins-approval-for-generic-temozolomide-in-australia-220312/ 2012-03-22T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/vistagen-vala-sciences-sign-strategic-drug-screening-collaboration-220312/ 2012-03-22T05:56:00+00:00 https://www.pharmaceutical-business-review.com/news/pharma-ereport-launches-centrality-software-230312/ 2012-03-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/grnenthal-affiliates-adopt-veeva-crm-solution-230312/ 2012-03-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pure-health-unveils-red-raspberry-ketone-supplement-230312/ 2012-03-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-invests-in-uk-manufacturing-facilities-230312/ 2012-03-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bend-research-to-expand-scientific-and-engineering-expertise-230312/ 2012-03-23T01:53:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-extracts-set-to-take-up-contract-manufacturing-orders-230312/ 2012-03-23T01:55:00+00:00 https://www.pharmaceutical-business-review.com/news/hyperion-signs-deal-with-ucyclyd-to-acquire-adjunctive-therapy-rights/ 2012-03-23T02:31:00+00:00 https://www.pharmaceutical-business-review.com/news/elite-to-develop-branded-prescription-pharmaceutical-product-in-us-230312/ 2012-03-23T03:38:00+00:00 https://www.pharmaceutical-business-review.com/news/emergent-wins-niaid-grant-to-develop-tuberculosis-vaccine-230312/ 2012-03-23T03:52:00+00:00 https://www.pharmaceutical-business-review.com/news/trimel-reports-positive-tefina-pk-study-data-230312/ 2012-03-23T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/styron-unveils-new-medical-grade-products-260312/ 2012-03-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/elsevier-announces-expanded-collaboration-with-exitcare-260312/ 2012-03-25T21:00:00+00:00 https://www.pharmaceutical-business-review.com/news/perkinelmer-introduces-chemistry-focused-informatics-solutions-260312/ 2012-03-25T21:06:00+00:00 https://www.pharmaceutical-business-review.com/news/ampio-fbm-enter-into-license-and-distribution-agreement-in-brazil-260312/ 2012-03-26T01:23:00+00:00 https://www.pharmaceutical-business-review.com/news/amylin-eli-lilly-receive-european-approval-for-expanded-use-of-byetta-260312/ 2012-03-26T01:27:00+00:00 https://www.pharmaceutical-business-review.com/news/lipotriad-unveils-new-eye-vitamin-260312/ 2012-03-26T01:34:00+00:00 https://www.pharmaceutical-business-review.com/news/tahitian-noni-introduces-seven-new-fit-body-supplements-260312/ 2012-03-26T02:10:00+00:00 https://www.pharmaceutical-business-review.com/news/mallinckrodt-launches-morphine-sulfate-oral-solution-in-us-260312/ 2012-03-26T02:32:00+00:00 https://www.pharmaceutical-business-review.com/news/argentina-government-to-produce-viagra-drug-260312/ 2012-03-26T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/dificlir-drug-reports-benefits-in-treating-bacterial-infection-260312/ 2012-03-26T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/quidel-receives-510k-clearance-for-influenza-ab-assay-260312/ 2012-03-26T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/taibang-wins-approval-to-begin-clinical-trials-for-human-fibrinogen-in-china-260312/ 2012-03-26T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/pozen-reports-positive-results-from-phase-iii-trials-of-pa32540-260312/ 2012-03-26T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/positron-wins-approval-for-radiopharmaceutical-manufacturing-facility-in-indiana-260312/ 2012-03-26T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-enters-into-patent-settlement-agreement-with-genentech-and-city-of-hope-270312/ 2012-03-27T00:28:00+00:00 https://www.pharmaceutical-business-review.com/news/bend-unveils-formulation-production-optimization-service-270312/ 2012-03-27T00:45:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-to-purchase-natur-produkt-270312/ 2012-03-27T00:49:00+00:00 https://www.pharmaceutical-business-review.com/news/sefar-adds-new-white-room-to-enhance-sefar-pharma-grade-product-line-270312/ 2012-03-27T01:19:00+00:00 https://www.pharmaceutical-business-review.com/news/genvec-wins-niaid-grant-to-advance-malaria-vaccine-program-270312/ 2012-03-27T01:23:00+00:00 https://www.pharmaceutical-business-review.com/news/insys-launches-fentanyl-sublingual-spray-for-cancer-pain-270312/ 2012-03-27T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmaform-corcept-sign-manufacturing-contract-for-korlym-270312/ 2012-03-27T01:58:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-teva-dry-nasal-aerosol-corticosteroid-270312/ 2012-03-27T02:21:00+00:00 https://www.pharmaceutical-business-review.com/news/bausch-lomb-to-purchase-ista-270312/ 2012-03-27T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/hanmi-gsk-enter-ebf-products-development-alliance-270312/ 2012-03-27T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-signs-multiproduct-agreement-with-tolmar-270312/ 2012-03-27T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/novasep-opens-new-expanded-shanghai-facilities-270312/ 2012-03-27T06:38:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-regeneron-report-phase-ii-data-of-lipid-lowering-pcsk9-antibody-270312/ 2012-03-27T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmaceutical-associates-selects-pilgrim-quality-and-compliance-solutions-280312/ 2012-03-27T19:34:00+00:00 https://www.pharmaceutical-business-review.com/news/labconnect-unveils-clinical-trial-sample-tracking-solution-280312/ 2012-03-28T00:20:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-tsinghua-university-extend-drug-discovery-partnership-280312/ 2012-03-28T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-asks-map-to-address-levadex-manufacturing-issues-280312/ 2012-03-28T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-to-partner-with-fujifilm-for-japanese-jv-280312/ 2012-03-28T01:43:00+00:00 https://www.pharmaceutical-business-review.com/news/moberg-signs-distribution-agreement-with-pharmaplan-in-south-africa-280312/ 2012-03-28T01:45:00+00:00 https://www.pharmaceutical-business-review.com/news/pharming-joins-hyupjin-to-commercialize-ruconest-in-korea-280312/ 2012-03-28T02:57:00+00:00 https://www.pharmaceutical-business-review.com/news/acadia-wins-mjff-grant-to-develop-parkinsons-disease-therapy-280312/ 2012-03-28T05:14:00+00:00 https://www.pharmaceutical-business-review.com/news/celtic-opens-new-adc-development-company-280312/ 2012-03-28T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/dara-biosciences-innocutis-to-co-promote-bionect-280312/ 2012-03-28T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/diagenic-and-ge-healthcare-to-develop-blood-test-for-alzheimers-280312/ 2012-03-28T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-affymax-anemia-drug-280312/ 2012-03-28T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/morphotek-completes-enrollment-in-phase-iii-ovarian-cancer-trial-280312/ 2012-03-28T05:46:00+00:00 https://www.pharmaceutical-business-review.com/news/connexus-burmans-partner-to-develop-data-management-and-portal-tool-290312/ 2012-03-29T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-files-patent-infringement-lawsuit-against-par-290312/ 2012-03-29T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-reaches-milestone-in-strategic-alliance-with-novartis-290312/ 2012-03-29T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/medefile-to-market-iphr-solutions-in-spain-290312/ 2012-03-29T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-ngm-enter-into-research-collaboration-290312/ 2012-03-29T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-launches-generic-seroquel-tablets-in-us-290312/ 2012-03-29T01:36:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-phase-ii-psoriasis-study-meets-primary-endpoint-290312/ 2012-03-29T02:19:00+00:00 https://www.pharmaceutical-business-review.com/news/trillium-initiates-phase-i-trial-of-tti-1612-in-icbps-patients-290312/ 2012-03-29T02:26:00+00:00 https://www.pharmaceutical-business-review.com/news/compugen-expands-operations-to-california-290312/ 2012-03-29T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-affymax-omontys-injection-290312/ 2012-03-29T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/intelsius-joins-biocore-to-expand-operations-in-south-korea-290312/ 2012-03-29T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/nile-phase-i-trial-of-cenderitide-meets-primary-end-point-290312/ 2012-03-29T06:39:00+00:00 https://www.pharmaceutical-business-review.com/news/plx-pharma-wins-grant-to-conduct-patent-ductus-arteriosus-research-290312/ 2012-03-29T06:50:00+00:00 https://www.pharmaceutical-business-review.com/news/optimer-astellas-sign-license-agreement-for-fidaxomicin-tablets-in-japan-300312/ 2012-03-30T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/depomed-receives-25m-license-fee-from-boehringer-300312/ 2012-03-30T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-astellas-revise-lipitor-development-and-marketing-agreement-300312/ 2012-03-30T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/bioseek-extends-collaboration-agreement-with-merck-300312/ 2012-03-30T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-canada-to-sell-mirabel-manufacturing-facility-to-halo-300312/ 2012-03-30T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/veloxis-completes-patient-enrollment-in-lcp-tacro-3002-pivotal-phase-iii-trial-300312/ 2012-03-30T02:18:00+00:00 https://www.pharmaceutical-business-review.com/news/akesogen-london-genetics-sign-strategic-alliance-to-support-drug-development-300312/ 2012-03-30T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/covis-announces-availability-of-zantac-injection-in-us-puerto-rico-300312/ 2012-03-30T05:10:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-seeks-fda-approval-for-kynamro-300312/ 2012-03-30T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/panacea-opens-cancer-drug-production-facility-in-india-300312/ 2012-03-30T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/zogenix-and-battelle-strike-dosepro-marketing-deal-300312/ 2012-03-30T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/pharma-manufacturer-adopts-alscg-membermatch-solution-020412/ 2012-04-01T22:43:00+00:00 https://www.pharmaceutical-business-review.com/news/sunpeaks-ventures-introduces-clotamin-in-south-florida-020412/ 2012-04-02T00:42:00+00:00 https://www.pharmaceutical-business-review.com/news/csl-behring-initiates-phase-i-hemophilia-study-020412/ 2012-04-02T01:02:00+00:00 https://www.pharmaceutical-business-review.com/news/accuray-university-of-heidelberg-collaborate-for-radiation-oncology-research-020412/ 2012-04-02T02:28:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-for-threshold-cancer-candidate-020412/ 2012-04-02T02:32:00+00:00 https://www.pharmaceutical-business-review.com/news/htg-partners-with-sanofi-to-identify-b-cell-malignancy-biomarkers-020412/ 2012-04-02T02:36:00+00:00 https://www.pharmaceutical-business-review.com/news/raptor-submits-nda-for-cysteamine-bitartrate-delayed-release-capsules-020412/ 2012-04-02T04:16:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmax-breaks-ground-on-pharma-production-facility-at-dubiotech-020412/ 2012-04-02T04:23:00+00:00 https://www.pharmaceutical-business-review.com/news/ranbaxy-begins-anti-cholesterol-drug-exports-to-us-020412/ 2012-04-02T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/ranbaxy-gains-approval-to-manufacture-ran-rosuvastatin-tablets-in-canada-020412/ 2012-04-02T06:02:00+00:00 https://www.pharmaceutical-business-review.com/news/restore-health-unveils-new-line-of-pharmaceutical-grade-nutritional-supplements-020412/ 2012-04-02T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-prevent2-trial-fails-to-meet-primary-endpoint-020412/ 2012-04-02T06:10:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-unveils-generic-provigil-020412/ 2012-04-02T06:16:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-phase-iii-copd-studies-meet-primary-end-points-030412/ 2012-04-03T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-wins-japanese-marketing-approval-for-kiklin-capsules-030412/ 2012-04-03T00:56:00+00:00 https://www.pharmaceutical-business-review.com/news/musclepharm-inaugurates-new-office-in-canada-030412/ 2012-04-03T00:57:00+00:00 https://www.pharmaceutical-business-review.com/news/schiff-nutrition-takes-over-airborne-for-150m-030412/ 2012-04-03T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/ablynx-reaches-milestone-in-collaboration-with-novartis-030412/ 2012-04-03T02:16:00+00:00 https://www.pharmaceutical-business-review.com/news/american-regent-recalls-cyanocobalamin-injection-030412/ 2012-04-03T02:26:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-minophagen-sign-licensing-agreement-for-bexarotene-030412/ 2012-04-03T02:39:00+00:00 https://www.pharmaceutical-business-review.com/news/critical-outcome-wins-us-patent-for-oncology-drug-040312/ 2012-04-03T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-bans-pax-all-manufacturing-drugs-in-us-040312/ 2012-04-03T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/indian-healthcare-opens-adc-unit-in-scotland-030412/ 2012-04-03T05:52:00+00:00 https://www.pharmaceutical-business-review.com/news/tai-tien-launches-simponi-solution-for-injection-in-taiwan-030412/ 2012-04-03T06:43:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-launches-generic-avapro-and-avalide-tablets-in-us-040312/ 2012-04-03T06:47:00+00:00 https://www.pharmaceutical-business-review.com/news/marina-completes-dosing-of-second-cohort-in-phase-ib-start-fap-trial-040412/ 2012-04-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cegedim-unveils-new-version-of-aggregatespend360-cloud-based-technology-040412/ 2012-04-03T23:54:00+00:00 https://www.pharmaceutical-business-review.com/news/ingenuity-launches-ireport-solution-for-gene-expression-analysis-040412/ 2012-04-04T00:11:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-unveils-generic-mesnex-injection-040412/ 2012-04-04T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/quidel-gains-ce-mark-for-direct-c-difficile-tox-ab-assay-040412/ 2012-04-04T01:31:00+00:00 https://www.pharmaceutical-business-review.com/news/ajinomoto-albireo-sign-licensing-agreement-for-elobixibat-040412/ 2012-04-04T02:24:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-amgen-enter-into-development-and-commercialization-agreement-040412/ 2012-04-04T02:27:00+00:00 https://www.pharmaceutical-business-review.com/news/synageva-mitsubishi-extend-development-collaboration-040412/ 2012-04-04T02:41:00+00:00 https://www.pharmaceutical-business-review.com/news/codexis-merck-develop-new-process-to-produce-boceprevir-040412/ 2012-04-04T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/owh-signs-patent-agreement-with-eisai-for-pro-drug-technology-040412/ 2012-04-04T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/polytherics-joins-spirogen-to-develop-antibody-drug-conjugates-040412/ 2012-04-04T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-novo-nordisk-levemir-label-update-040412/ 2012-04-04T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/mereco-metaduct-1202-silver-adhesive-meets-packaging-requirements-040412/ 2012-04-04T07:55:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-names-new-ceo-040412/ 2012-04-04T07:58:00+00:00 https://www.pharmaceutical-business-review.com/news/opko-health-takes-over-als-distribuidora-050412/ 2012-04-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/xencor-reaches-milestone-in-technology-license-agreement-with-boehringer-050412/ 2012-04-05T00:40:00+00:00 https://www.pharmaceutical-business-review.com/news/lixte-receives-notice-of-allowance-for-histone-deacetylase-inhibitor-patent-050412/ 2012-04-05T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/pharma-and-cro-adopt-facts-clinical-trial-design-software-050412/ 2012-04-05T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/valuecentric-releases-valuetrak-v50-for-healthcare-companies-050412/ 2012-04-05T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/axellus-to-distribute-new-probiotic-lactose-free-supplement-in-finland-050412/ 2012-04-05T01:10:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-reports-positive-results-from-phase-ii-hepatitis-c-studies-050412/ 2012-04-05T02:54:00+00:00 https://www.pharmaceutical-business-review.com/news/stellar-launches-anti-klh-elisa-assays-for-pharmaceutical-immunotoxicology-research-050412/ 2012-04-05T02:57:00+00:00 https://www.pharmaceutical-business-review.com/news/ibbme-researchers-develop-new-method-to-produce-stem-cells-050412/ 2012-04-05T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/aecom-to-provide-design-construction-advisory-services-to-usaid-050412/ 2012-04-05T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/mpi-edge-therapeutics-to-advance-therapies-for-brain-disorders-050412/ 2012-04-05T06:12:00+00:00 https://www.pharmaceutical-business-review.com/news/vitalmax-unveils-advanced-vitamin-formula-to-maintain-glucose-levels-050412/ 2012-04-05T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-confirms-favorable-court-ruling-over-generic-sanctura-xr-050412/ 2012-04-05T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/xenoport-receives-us-patent-covering-composition-formulations-of-xp23829-050412/ 2012-04-05T07:44:00+00:00 https://www.pharmaceutical-business-review.com/news/newron-zambon-sign-collaboration-and-licence-agreement-for-safinamide-060412/ 2012-04-06T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-files-suit-against-fda-to-overturn-provigil-decision-060412/ 2012-04-06T01:47:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-regeneron-cancer-drug-gains-fda-priority-review-status-060412/ 2012-04-06T01:52:00+00:00 https://www.pharmaceutical-business-review.com/news/akebia-phase-ii-ckd-study-meets-primary-endpoint-060412/ 2012-04-06T02:26:00+00:00 https://www.pharmaceutical-business-review.com/news/sucampo-reports-positive-data-from-phase-iii-trial-of-lubiprostone-060412/ 2012-04-06T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/american-cryostem-pgen-to-develop-cellular-therapies-for-wound-healing/ 2012-04-06T03:53:00+00:00 https://www.pharmaceutical-business-review.com/news/advaxis-signs-research-collaboration-with-karolinska-institutet-060412/ 2012-04-06T03:57:00+00:00 https://www.pharmaceutical-business-review.com/news/medical-marijuana-inks-deal-to-buy-cannabinoid-delivery-method-060412/ 2012-04-06T04:00:00+00:00 https://www.pharmaceutical-business-review.com/news/phosphagenics-enters-manufacturing-deal-with-intas-060412/ 2012-04-06T04:04:00+00:00 https://www.pharmaceutical-business-review.com/news/purdue-pharma-announces-availability-of-insomnia-drug-060412/ 2012-04-06T04:09:00+00:00 https://www.pharmaceutical-business-review.com/news/tonix-pharma-announces-pk-data-from-tnx-102-study-060412/ 2012-04-06T04:15:00+00:00 https://www.pharmaceutical-business-review.com/news/one-eleven-roi-to-develop-e-sampling-products-for-pharma-marketing-090412/ 2012-04-08T21:52:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-novo-nordisk-victoza-label-change-090412/ 2012-04-09T00:46:00+00:00 https://www.pharmaceutical-business-review.com/news/par-pharmaceutical-initiates-shipment-of-generic-sleep-disorder-drug-090412/ 2012-04-09T00:51:00+00:00 https://www.pharmaceutical-business-review.com/news/presage-biosciences-millennium-sign-cancer-research-agreement-090412/ 2012-04-09T01:54:00+00:00 https://www.pharmaceutical-business-review.com/news/biocon-invests-in-new-integrated-research-and-development-centre-090412/ 2012-04-09T02:55:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-glenmark-generic-contraceptive-product-090412/ 2012-04-09T02:59:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-forms-drug-discovery-alliance-with-sgc-090412/ 2012-04-09T03:17:00+00:00 https://www.pharmaceutical-business-review.com/news/image-sports-gnc-partner-to-launch-new-line-of-sports-nutrition-supplements-090412/ 2012-04-09T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/nepal-dda-to-formulate-good-manufacturing-practice-regulations-090412/ 2012-04-09T04:50:00+00:00 https://www.pharmaceutical-business-review.com/news/indian-government-to-address-pharma-industry-issues-090412/ 2012-04-09T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/mda-funds-catabasis-to-test-therapies-for-muscle-disorder-090412/ 2012-04-09T07:03:00+00:00 https://www.pharmaceutical-business-review.com/news/pacira-launches-exparel-in-us-090412/ 2012-04-09T07:05:00+00:00 https://www.pharmaceutical-business-review.com/news/sigma-aldrich-purchases-all-outstanding-shares-of-research-organics-090412/ 2012-04-09T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/ophthalix-completes-preclinical-studies-of-cf101-100412/ 2012-04-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/redhill-biopharma-reports-positive-preliminary-results-from-ondansetron-study-100412/ 2012-04-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/affymax-earns-50m-development-milestone-payment-from-takeda-100412/ 2012-04-10T01:10:00+00:00 https://www.pharmaceutical-business-review.com/news/epicept-receives-fda-fast-track-designation-for-amiket-100412/ 2012-04-10T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/johnson-johnson-to-increase-production-of-cancer-drug-100412/ 2012-04-10T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/regenerx-wins-t4-patents-allowances-in-mexico-israel-100412/ 2012-04-10T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/syndax-begins-phase-iii-breast-cancer-study-100412/ 2012-04-10T02:14:00+00:00 https://www.pharmaceutical-business-review.com/news/therapeuticsmd-launches-prenatal-vitamin-supplement-100412/ 2012-04-10T02:51:00+00:00 https://www.pharmaceutical-business-review.com/news/anaptysbio-celgene-sign-strategic-antibody-discovery-partnership-100412/ 2012-04-10T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/hds-signs-letter-of-intent-to-export-clotamin-to-russian-pharmacies-100412/ 2012-04-10T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/nuron-enters-into-licensing-agreement-for-amyloid-beta-42-dna-vaccine-100412/ 2012-04-10T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/omkar-speciality-chemicals-advances-into-pharmaceutical-business-100412/ 2012-04-10T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/china-cuba-enter-manufacturing-agreement-100412/ 2012-04-10T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/neutra-to-commence-clinical-trials-of-pure-plus-weight-loss-formula-100412/ 2012-04-10T08:14:00+00:00 https://www.pharmaceutical-business-review.com/news/surya-pharma-closes-two-api-plants-in-india-100412/ 2012-04-10T08:17:00+00:00 https://www.pharmaceutical-business-review.com/news/glpi-selects-omnicomm-trialmaster-suite-for-pivotal-device-study-110412/ 2012-04-10T19:23:00+00:00 https://www.pharmaceutical-business-review.com/news/dataflux-expands-agreement-with-stayinfront-110412/ 2012-04-10T23:00:00+00:00 https://www.pharmaceutical-business-review.com/news/spectrum-pharma-adopts-pharmavigilant-i-vault-solution-110412/ 2012-04-10T23:14:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-receives-fda-approval-for-vancomycin-hydrochloride-capsules-110412/ 2012-04-11T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/winston-receives-sbir-grant-to-develop-postherpetic-neuralgia-therapy-110412/ 2012-04-11T00:57:00+00:00 https://www.pharmaceutical-business-review.com/news/certara-unveils-updated-version-of-phoenix-110412/ 2012-04-11T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-updates-labels-for-certain-contraceptive-pills-in-us-110412/ 2012-04-11T01:39:00+00:00 https://www.pharmaceutical-business-review.com/news/omeros-initiates-enrollment-in-phase-iii-trial-of-oms302-110412/ 2012-04-11T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/ibio-produces-palivizumab-using-ibiolaunch-technology-110412/ 2012-04-11T02:41:00+00:00 https://www.pharmaceutical-business-review.com/news/qrxpharma-completes-phase-i-studies-for-moxduo-cr-110412/ 2012-04-11T04:39:00+00:00 https://www.pharmaceutical-business-review.com/news/enzo-biochem-introduces-colorectal-cancer-diagnostic-test-110412/ 2012-04-11T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/genetex-to-launch-new-antibody-against-caix-cancer-biomarker-110412/ 2012-04-11T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/regenx-wins-fda-orphan-designation-for-familial-hypercholesterolemia-therapy-110412/ 2012-04-11T07:11:00+00:00 https://www.pharmaceutical-business-review.com/news/chhattisgarh-plans-to-become-future-hub-of-pharmaceutical-production-in-india-170412/ 2012-04-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/hds-ds-healthcare-enter-agreement-to-launch-clotamin-in-uk-120412/ 2012-04-11T23:17:00+00:00 https://www.pharmaceutical-business-review.com/news/lorus-therapeutics-receives-us-patent-for-anticancer-drug-120412/ 2012-04-12T00:31:00+00:00 https://www.pharmaceutical-business-review.com/news/gnt-pharma-ttc-enter-into-strategic-partnership-in-japan-120412/ 2012-04-12T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-launches-multiple-sclerosis-drug-in-canada-120412/ 2012-04-12T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/threshold-receives-20m-milestone-payment-from-merck-120412/ 2012-04-12T01:50:00+00:00 https://www.pharmaceutical-business-review.com/news/medidata-unveils-new-randomization-and-trial-supply-management-solution-120412/ 2012-04-12T01:55:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-agennix-sign-deal-for-production-of-talactoferrin-120412/ 2012-04-12T03:20:00+00:00 https://www.pharmaceutical-business-review.com/news/quest-gains-fda-clearance-for-simplexa-c-difficile-molecular-test-120412/ 2012-04-12T04:50:00+00:00 https://www.pharmaceutical-business-review.com/news/safc-launches-chozn-platform-to-produce-recombinant-protein-drugs-120412/ 2012-04-12T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/skyepharma-signs-development-deal-with-respivert-120412/ 2012-04-12T04:58:00+00:00 https://www.pharmaceutical-business-review.com/news/cardio3-wins-gmp-certification-for-new-production-facilities-in-belgium-120412/ 2012-04-12T07:18:00+00:00 https://www.pharmaceutical-business-review.com/news/gamma-pharmaceuticals-signs-distribution-agreement-for-gamma-energy-gel-120412/ 2012-04-12T07:21:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-america-to-take-over-url-pharma-120412/ 2012-04-12T07:27:00+00:00 https://www.pharmaceutical-business-review.com/news/alitair-gains-notice-of-allowance-for-rea-drug-delivery-technology-130412/ 2012-04-13T00:36:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-launches-blood-pressure-drug-in-us-130412/ 2012-04-13T00:41:00+00:00 https://www.pharmaceutical-business-review.com/news/ampio-completes-enrollment-in-multiple-indication-diagnostic-trials-130412/ 2012-04-13T00:46:00+00:00 https://www.pharmaceutical-business-review.com/news/biodis-signs-distribution-agreement-with-biotd-for-citofem-130412/ 2012-04-13T01:36:00+00:00 https://www.pharmaceutical-business-review.com/news/opko-initiates-enrollment-in-phase-iii-cinv-trials-130412/ 2012-04-13T01:39:00+00:00 https://www.pharmaceutical-business-review.com/news/ambry-genetics-launches-fluidigm-based-genomic-research-services-130412/ 2012-04-13T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-introduces-generic-mucinex-600mg-tablets-130412/ 2012-04-13T01:49:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-hope-sodium-nitrite-injection-130412/ 2012-04-13T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/indian-state-pcb-orders-closure-of-eight-drug-manufacturing-units-130412/ 2012-04-13T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-takes-over-pedinol-pharmacal-130412/ 2012-04-13T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-millennium-join-ventana-to-develop-adcetris-companion-test-130412/ 2012-04-13T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/insmed-doses-first-patient-in-european-study-of-arikace-170412/ 2012-04-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cms-grants-q-code-for-affymax-omontys-injection-180412/ 2012-04-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-wins-fda-approval-for-generic-lescol-capsules-160412/ 2012-04-16T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/qgc-initiates-phase-i-study-of-qgc001-drug-160412/ 2012-04-16T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/biodel-announces-positive-top-line-results-from-phase-i-rhi-trial-160412/ 2012-04-16T01:16:00+00:00 https://www.pharmaceutical-business-review.com/news/addex-announces-positive-data-from-gaba-br-pam-studies-160412/ 2012-04-16T01:24:00+00:00 https://www.pharmaceutical-business-review.com/news/bosch-finalizes-purchase-of-eisai-machinery-160412/ 2012-04-16T01:49:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-conformetrix-enter-into-research-collaboration-agreement-160412/ 2012-04-16T07:06:00+00:00 https://www.pharmaceutical-business-review.com/news/spectrum-chemicals-signs-distribution-agreement-with-tci-160412/ 2012-04-16T07:21:00+00:00 https://www.pharmaceutical-business-review.com/news/vanda-eli-lilly-sign-licensing-contract-for-nk-1r-antagonist-160412/ 2012-04-16T07:38:00+00:00 https://www.pharmaceutical-business-review.com/news/nascent-catalent-sign-product-development-agreement-170412/ 2012-04-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/microphage-keypath-test-gains-expanded-fda-clearance-170412/ 2012-04-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/perkinelmer-unveils-new-ensemble-for-biology-informatics-platform-170412/ 2012-04-16T23:31:00+00:00 https://www.pharmaceutical-business-review.com/news/reliv-launches-kids-nutritional-supplement-170412/ 2012-04-16T23:42:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-veracyte-announce-availability-of-afirma-thyroid-fna-analysis-in-us-170412/ 2012-04-17T00:34:00+00:00 https://www.pharmaceutical-business-review.com/news/dfh-pharma-niaid-to-develop-second-generation-hiv-maturation-inhibitor-drugs-170412/ 2012-04-17T01:23:00+00:00 https://www.pharmaceutical-business-review.com/news/gg-vitamins-unveils-new-line-of-multivitamins-for-women-170412/ 2012-04-17T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/aptiv-releases-adaptive-design-and-simulation-trial-software-170412/ 2012-04-17T02:42:00+00:00 https://www.pharmaceutical-business-review.com/news/indian-pharma-units-face-faulty-government-policy-says-ipa-chief-170412/ 2012-04-17T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/jubilant-life-sciences-opens-new-sez-in-india-170412/ 2012-04-17T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/morphotek-initiates-phase-ii-colorectal-cancer-study-170412/ 2012-04-17T04:58:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-endocyte-to-develop-investigational-therapeutic-candidate-vintafolide-170412/ 2012-04-17T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmatek-enhances-liquid-encapsulation-capabilities-at-production-site-170412/ 2012-04-17T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/vermillion-receives-notice-of-allowance-for-biomarker-patent-in-us-170412/ 2012-04-17T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/vistagen-signs-licensing-deal-for-stem-cell-culture-technology-170412/ 2012-04-17T06:07:00+00:00 https://www.pharmaceutical-business-review.com/news/perkinelmer-launches-new-axion-dsa-system-for-spectrometry-sample-preparation-180412/ 2012-04-17T20:17:00+00:00 https://www.pharmaceutical-business-review.com/news/bioclinica-collaborates-with-paragon-to-build-clinical-architecture-180412/ 2012-04-17T23:33:00+00:00 https://www.pharmaceutical-business-review.com/news/extedo-launches-new-solution-to-support-xevmpd-submission-standard-180412/ 2012-04-17T23:36:00+00:00 https://www.pharmaceutical-business-review.com/news/nouveau-in-talks-with-distributors-for-azul-instant-180412/ 2012-04-18T00:03:00+00:00 https://www.pharmaceutical-business-review.com/news/biota-signs-development-manufacturing-deal-with-amri-180412/ 2012-04-18T00:37:00+00:00 https://www.pharmaceutical-business-review.com/news/five-prime-gsk-sign-strategic-drug-discovery-alliance-180412/ 2012-04-18T00:46:00+00:00 https://www.pharmaceutical-business-review.com/news/idera-begins-phase-ii-plaque-psoriasis-trial-180412/ 2012-04-18T01:41:00+00:00 https://www.pharmaceutical-business-review.com/news/medgenics-seeks-fda-approval-for-phase-iib-anemia-trial-180412/ 2012-04-18T01:44:00+00:00 https://www.pharmaceutical-business-review.com/news/rockland-limr-sign-licensing-deal-for-antibodies-180412/ 2012-04-18T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-reports-positive-levodopa-carbidopa-intestinal-gel-study-data-180412/ 2012-04-18T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/inspiration-seeks-fda-approval-for-hemophilia-drug-180412/ 2012-04-18T05:11:00+00:00 https://www.pharmaceutical-business-review.com/news/newlink-gains-notice-of-allowance-for-japanese-patent-180412/ 2012-04-18T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/proimmune-unveils-b-cell-elispot-assay-180412/ 2012-04-18T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-launches-insomnia-drug-in-japan-200412/ 2012-04-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/us-extends-patent-protection-for-bdsi-bioerodible-mucoadhesive-products-190412/ 2012-04-19T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-to-expand-operations-in-ireland-190412/ 2012-04-19T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-to-purchase-certain-assets-from-atlantis-190412/ 2012-04-19T01:19:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-to-start-production-at-moratuwa-plant-190412/ 2012-04-19T04:44:00+00:00 https://www.pharmaceutical-business-review.com/news/rosetta-green-produces-growth-harmone-from-algae-190412/ 2012-04-19T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/boston-receives-first-purchase-order-for-sugardown-in-hong-kong-190412/ 2012-04-19T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/cell-therapeutics-signs-asset-purchase-agreement-to-acquire-pacritinib-190412/ 2012-04-19T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/mission-pharmacal-signs-patent-technology-licensing-deal-with-effrx-190412/ 2012-04-19T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-metabolon-enter-into-drug-discovery-alliance-190412/ 2012-04-19T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-onco-therapies-cisplatin-injection-190412/ 2012-04-19T08:07:00+00:00 https://www.pharmaceutical-business-review.com/news/redhill-reports-positive-pivotal-bioequivalence-trial-data-with-rhb-102-190412/ 2012-04-19T08:12:00+00:00 https://www.pharmaceutical-business-review.com/news/synairgen-reports-positive-phase-ii-asthma-trial-data-190412/ 2012-04-19T08:20:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-mjff-partner-to-conduct-phase-ib-parkinsons-disease-trial-200412/ 2012-04-20T00:31:00+00:00 https://www.pharmaceutical-business-review.com/news/hgs-rejects-26bn-takeover-bid-by-gsk-200412/ 2012-04-20T01:10:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-to-construct-new-manufacturing-site-in-georgia-200412/ 2012-04-20T02:06:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designation-for-sk-biopharmaceuticals-carisbamate-200412/ 2012-04-20T02:10:00+00:00 https://www.pharmaceutical-business-review.com/news/par-gains-rights-to-market-distribute-dexlansoprazole-capsules-in-us-200412/ 2012-04-20T02:22:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-introduces-generic-version-of-fortamet-200412/ 2012-04-20T02:30:00+00:00 https://www.pharmaceutical-business-review.com/news/slp-releases-new-version-simulation-modeling-software-200412/ 2012-04-20T03:06:00+00:00 https://www.pharmaceutical-business-review.com/news/alder-biopharma-closes-38m-in-series-d-financing-200412/ 2012-04-20T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-palatin-initiate-phase-i-obesity-trial-200412/ 2012-04-20T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-dual-oral-therapy-shows-efficacy-in-hcv-patients-200412/ 2012-04-20T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/xencor-achieves-milestone-in-collaboration-with-csl-200412/ 2012-04-20T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/adimab-initiates-new-independent-research-collaborations-200412/ 2012-04-20T07:27:00+00:00 https://www.pharmaceutical-business-review.com/news/rosetta-wins-european-patent-covering-core-element-of-microrna-technology-200412/ 2012-04-20T08:32:00+00:00 https://www.pharmaceutical-business-review.com/news/terapia-ranbaxy-to-launch-daiichi-antihypertensive-drug-in-romania-230412/ 2012-04-23T00:48:00+00:00 https://www.pharmaceutical-business-review.com/news/acetylon-wins-us-patent-covering-composition-of-matter-claims-of-acy-1215/ 2012-04-23T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-presents-positive-phase-i-aln-pcs-trial-data-230412/ 2012-04-23T01:47:00+00:00 https://www.pharmaceutical-business-review.com/news/incyte-achieves-regulatory-milestone-under-ruxolitinib-license-agreement-with-novartis-230412/ 2012-04-23T01:49:00+00:00 https://www.pharmaceutical-business-review.com/news/amag-gains-positive-chmp-opinion-for-ferumoxytol-approval-230412/ 2012-04-23T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-to-divest-otc-brands-to-aspen-230412/ 2012-04-23T03:02:00+00:00 https://www.pharmaceutical-business-review.com/news/chmp-recommends-skyepharma-flutiform-clearance-230412/ 2012-04-23T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/micurx-completes-phase-i-trial-for-mrx-i-230412/ 2012-04-23T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmaceutical-companies-seek-separate-zone-in-jammu-india-230412/ 2012-04-23T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/biotime-lifemap-to-take-over-xennex-230412/ 2012-04-23T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/shasun-pharma-to-invest-50m-for-capacity-expansion-230412/ 2012-04-23T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-updates-gilenya-label-to-include-cardiovascular-monitoring-230412/ 2012-04-23T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-ardea-biosciences-sign-definitive-merger-agreement-230412/ 2012-04-23T08:24:00+00:00 https://www.pharmaceutical-business-review.com/news/biotech-firm-licenses-xybion-pristima-preclinical-solution-240412/ 2012-04-23T23:12:00+00:00 https://www.pharmaceutical-business-review.com/news/mannatech-introduces-nutriverus-nutritional-supplement-240412/ 2012-04-23T23:22:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-xarelto-wins-cdr-recommendation-for-stroke-prevention-in-af-patients-240412/ 2012-04-24T00:44:00+00:00 https://www.pharmaceutical-business-review.com/news/spectrum-embarks-on-manufacturing-plan-to-expand-fusilev-capacity-240412/ 2012-04-24T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/ezose-hirosaki-university-sign-glycomics-research-collaboration-240412/ 2012-04-24T00:57:00+00:00 https://www.pharmaceutical-business-review.com/news/japan-tobacco-torii-report-positive-top-line-results-from-phase-iii-zerenex-study-240412/ 2012-04-24T01:31:00+00:00 https://www.pharmaceutical-business-review.com/news/nextbio-upgrades-life-science-platform-to-aid-translational-research-240412/ 2012-04-24T03:07:00+00:00 https://www.pharmaceutical-business-review.com/news/xrock-issues-voluntary-recall-of-certain-supplement-products-240412/ 2012-04-24T03:11:00+00:00 https://www.pharmaceutical-business-review.com/news/battelle-develops-new-test-to-identify-potential-asd-biomarker-240412/ 2012-04-24T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/life-technologies-to-invest-20m-in-cell-culture-facility-in-scotland-240412/ 2012-04-24T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/saladax-signs-distribution-contract-for-my5-fu-diagnostic-test-in-egypt-mena-region-240412/ 2012-04-24T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/tigenixs-european-production-facility-wins-manufacturing-license-240412/ 2012-04-24T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/wr-grace-formac-announce-use-of-silica-based-drug-delivery-technology-in-humans-230412/ 2012-04-24T08:40:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-drais-collaborate-to-develop-ulcerative-colitis-candidate-250412/ 2012-04-25T00:41:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-wins-final-fda-approval-for-generic-zyprexa-tablets-250412/ 2012-04-25T00:46:00+00:00 https://www.pharmaceutical-business-review.com/news/recordati-purchases-six-otc-pharmaceuticals-from-cilag-mcneil-250412/ 2012-04-25T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-new-production-process-to-manufacture-merck-sitagliptin-tablets-250412/ 2012-04-25T01:31:00+00:00 https://www.pharmaceutical-business-review.com/news/prometic-to-develop-affinity-resin-product-related-manufacturing-process-250412/ 2012-04-25T01:34:00+00:00 https://www.pharmaceutical-business-review.com/news/thomson-reuters-unveils-new-mobile-oncology-solution-250412/ 2012-04-25T02:52:00+00:00 https://www.pharmaceutical-business-review.com/news/dalton-to-manufacture-drdc-antiviral-agent-250412/ 2012-04-25T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/lupin-breaks-ground-on-formulation-plant-in-nagpur-250412/ 2012-04-25T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/ikaria-hepatorenal-syndrome-type-1-therapy-wins-approval-in-australia-250412/ 2012-04-25T05:18:00+00:00 https://www.pharmaceutical-business-review.com/news/nouveau-to-start-production-of-new-female-supplement-250412/ 2012-04-25T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/psivida-iluvien-gains-marketing-authorization-in-austria-250412/ 2012-04-25T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/reaction-biology-opens-protein-production-facility-250412/ 2012-04-25T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-plans-to-invest-in-manufacturing-facility-in-switzerland-250412/ 2012-04-25T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-unveils-sequencing-assays-to-identify-genetic-variations-in-leukemia-samples-260412/ 2012-04-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/prc-clinical-adds-simplectms-to-eclinical-services-260412/ 2012-04-25T21:06:00+00:00 https://www.pharmaceutical-business-review.com/news/oba-releases-new-web-based-version-of-irms-software-260412/ 2012-04-26T00:12:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-submits-cta-to-initiate-phase-i-alzheimers-study-260412/ 2012-04-26T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/ranbaxy-launches-new-malaria-drug-in-india-260412/ 2012-04-26T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/affymax-takeda-launch-omontys-injection-in-us-260412/ 2012-04-26T02:28:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-medicines-company-sign-development-commercialization-agreement-260412/ 2012-04-26T02:32:00+00:00 https://www.pharmaceutical-business-review.com/news/american-regent-recalls-epinephrine-injection-260412/ 2012-04-26T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/anthera-completes-patient-dosing-in-phase-iib-pearl-sc-study-260412/ 2012-04-26T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-oxford-university-enter-into-research-partnership-260412/ 2012-04-26T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/atheronova-signs-development-deal-with-frontage-260412/ 2012-04-26T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/vernalis-achieves-milestone-with-servier-260412/ 2012-04-26T05:46:00+00:00 https://www.pharmaceutical-business-review.com/news/mdxhealth-enters-marketing-deal-with-plus-diagnostics-260412/ 2012-04-26T08:34:00+00:00 https://www.pharmaceutical-business-review.com/news/irb-approves-anatabloc-clinical-study-270412/ 2012-04-26T23:33:00+00:00 https://www.pharmaceutical-business-review.com/news/antares-watson-pharmaceuticals-launch-gelnique-3-in-us-270412/ 2012-04-27T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/asahi-kasei-takes-over-zoll-medical-270412/ 2012-04-27T00:55:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-novartis-afinitor-to-treat-kidney-tumors-270412/ 2012-04-27T01:00:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-wins-fda-approval-for-votrient-cancer-drug-270412/ 2012-04-27T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/meridian-teva-settle-epinephrine-auto-injector-pending-patent-litigation-270412/ 2012-04-27T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/dynavax-submits-hepatitis-b-vaccine-bla-to-fda-270412/ 2012-04-27T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/cytrx-begins-phase-ii-pancreatic-ductual-adenocarcinomas-trial-270412/ 2012-04-27T02:03:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-seeks-additional-data-on-takeda-diabetes-drug-applications-270412/ 2012-04-27T05:13:00+00:00 https://www.pharmaceutical-business-review.com/news/hi-tech-pharmacal-acquires-marketing-rights-of-generic-lidocaine-5-ointment-270412/ 2012-04-27T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/pierre-fabre-forest-laboratories-report-positive-phase-iii-mdd-study-data-270412/ 2012-04-27T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/repligen-reports-positive-phase-i-spinal-muscular-atrophy-study-data-270412/ 2012-04-27T07:13:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-vyvanse-drug-meets-safety-efficacy-endpoints-270412/ 2012-04-27T07:17:00+00:00